Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1050.Time spend outdoors in summer,48360,0.0472912901249903,0.0219522222324648,0.00426493454935934,0.0903176457006213,0.031227736819937
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1060.Time spent outdoors in winter,44700,-0.00790947561292729,0.0249954189497599,-0.0569004967544567,0.0410815455286022,0.751673999322552
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1070.Time spent watching television (TV),49486,0.0600781104180441,0.0218838281221866,0.0171858072985584,0.10297041353753,0.00604940539341928
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1080.Time spent using computer,44621,-0.00486708626120922,0.0232662736754318,-0.0504689826650556,0.0407348101426372,0.834301485590088
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1090.Time spent driving,43517,-0.00782170675152031,0.0242798820453585,-0.055410275560423,0.0397668620573824,0.747344273245467
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1160.Sleep duration,51259,-0.0198487186269312,0.0205180858106784,-0.0600641668158608,0.0203667295619985,0.333364280684611
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34252,-0.0169895705573356,0.0167324485266743,-0.0497851696696172,0.015806028554946,0.309954713019938
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34252,0.0132132087020249,0.0164478407057643,-0.0190245590812732,0.0454509764853229,0.421796605546041
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34252,-0.00554495882518706,0.0194117473410371,-0.0435919836136198,0.0325020659632456,0.775152165431605
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34252,-0.0126535124766844,0.0201409445722399,-0.0521297638382745,0.0268227388849057,0.529855155885424
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34252,0.0147114531287845,0.020637494286051,-0.0257380356718754,0.0551609419294444,0.475954127876594
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34252,-0.00644902607281367,0.0395413278085756,-0.0839500285776218,0.0710519764319944,0.87044614650543
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34252,-0.00718646970573605,0.0410933851898257,-0.0877295046777944,0.0733565652663223,0.861176213999648
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34252,0.027323079712291,0.0289068476254034,-0.0293343416334997,0.0839805010580816,0.344572975136873
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34252,0.0102923072134043,0.0212206358802722,-0.0313001391119292,0.0518847535387378,0.627676580513842
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34252,0.0258388360255477,0.0149452391122033,-0.0034538326343708,0.0551315046854662,0.0838565484969319
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34252,0.0168669322299519,0.0211682837110407,-0.0246229038436878,0.0583567683035917,0.425584197235043
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34252,0.00946724820687976,0.0121674244321323,-0.0143809036800995,0.0333154000938591,0.436538665239496
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34252,-0.000263518872641481,0.0156395753054573,-0.0309170864713379,0.0303900487260549,0.986557011390469
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34252,0.0568679323565777,0.0236437610520448,0.0105261606945699,0.103209704018586,0.0161810638859658
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34252,0.00715802220642417,0.0225121809462823,-0.0369658524482892,0.0512818968611375,0.750520011548848
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34252,-0.0250134784234755,0.0277685673436837,-0.0794398704170955,0.0294129135701446,0.367724103112643
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34252,-0.0245169311885968,0.0262153909360678,-0.0758990974232898,0.0268652350460961,0.34970112025744
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34252,0.0275030488640372,0.0173833781402157,-0.0065683722907856,0.0615744700188599,0.113646588466464
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34252,0.0218269215929949,0.0165795489336832,-0.0106689943170242,0.0543228375030139,0.188036416376069
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34252,-0.0194888613152991,0.020407894363063,-0.0594883342669025,0.0205106116363044,0.339616706080133
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120040.Fatigue severity over the past week,34260,0.0458963477982913,0.0359286620266975,-0.0245238297740358,0.116316525370618,0.201479028954099
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34263,0.0638587567462359,0.0354646773388193,-0.00565201083784998,0.133369524330322,0.0717901994736923
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34260,0.0261321584525361,0.0388886954717951,-0.0500896846721823,0.102354001577254,0.501615731650083
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120098.Mobility problems today,34265,0.0425751641738098,0.0432653892680711,-0.0422249987916097,0.127375327139229,0.325115431913432
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120099.Self-care problems today,34265,0.137929006041506,0.0652742699200491,0.00999143699820962,0.265866575084802,0.0346186557373459
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120100.Problems doing usual activities,34265,0.0416374216934826,0.0406499779611349,-0.0380365351103418,0.121311378497307,0.305721491361624
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120101.Pain or discomfort today,34265,0.0283740950930104,0.035710984866604,-0.0416194352455333,0.0983676254315542,0.426894546941961
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120102.Anxiety or depression today,34265,-0.022537567465083,0.0421947810145119,-0.105239338253526,0.0601642033233603,0.593261877037513
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120103.Scale to indicate how health is today,34232,-0.00743639993443798,0.00526737971154363,-0.0177604641690635,0.00288766430018753,0.158043707200037
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34249,0.0148900914594888,0.0421168702784749,-0.0676589742863219,0.0974391572052996,0.723689164252322
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34235,-0.0691119322113032,0.0433351306369063,-0.15404878825964,0.0158249238370332,0.110781930476625
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34254,0.0445419345556174,0.0354499283015579,-0.0249399249154361,0.114023794026671,0.208972191735924
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34256,0.00861847651110335,0.0362330510648542,-0.0623983035760108,0.0796352565982175,0.811992592618935
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34251,-0.00959680648788768,0.0437500846859829,-0.0953469724724142,0.0761533594966388,0.826377711890245
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34226,-0.00196723105344529,0.0447467305272712,-0.0896708228868968,0.0857363607800062,0.964934199989876
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34257,0.0367999748234859,0.0448125705428923,-0.0510326634405829,0.124632613087555,0.411552562930978
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34242,0.0289103238086283,0.0660268145375527,-0.100502232684975,0.158322880302232,0.66149882972009
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34189,0.0618879289727721,0.0840527575087028,-0.102855475744285,0.22663133368983,0.461565713086968
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31294,0.011762527581051,0.046610658243874,-0.079594362576942,0.103119417739044,0.80077208413863
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48264,0.0633578993805894,0.0509135523445022,-0.036432663214635,0.163148461975814,0.213356568756836
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,46993,0.00413845187249191,0.0316847552740725,-0.0579636684646901,0.0662405722096739,0.896082321150666
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1289.Cooked vegetable intake,50266,-0.0263678529455595,0.0211568160032128,-0.0678352123118566,0.0150995064207375,0.212663371593939
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49745,-0.0696900482192909,0.0224767401021215,-0.113744458819449,-0.0256356376191327,0.00193375018040982
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1309.Fresh fruit intake,50238,-0.0971278643004911,0.0225895013798964,-0.141403287005088,-0.0528524415958941,1.71650498034736e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1319.Dried fruit intake,48732,-0.0783660006478128,0.0241742007725681,-0.125747434162046,-0.0309845671335794,0.00118966901016558
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X134.Number of self-reported cancers,51482,0.0878056398101192,0.0460549867911242,-0.00246213430048423,0.178073413920723,0.0565906458733047
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51482,0.0146005201424966,0.0206104418559345,-0.0257959458951349,0.0549969861801282,0.478700366547246
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X136.Number of operations, self-reported",51482,0.039625646362899,0.0204833984719245,-0.000521814642072918,0.079773107367871,0.0530588109782478
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X137.Number of treatments or medications taken,51482,0.0207799447028388,0.0204922598712083,-0.0193848846447294,0.060944774050407,0.310573165388773
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1438.Bread intake,50620,0.0144670239351161,0.00350223000612988,0.00760265312310157,0.0213313947471307,3.62595014882606e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1458.Cereal intake,49892,-0.0138301539498475,0.0213540559400591,-0.0556841035923633,0.0280237956926684,0.517211014462157
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1488.Tea intake,50412,0.00828151800785923,0.00330960725742937,0.00179468778329767,0.0147683482324208,0.0123460779961008
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1498.Coffee intake,49194,0.0461076484468667,0.0213466832391547,0.0042681492981235,0.0879471475956098,0.0307863257005533
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1528.Water intake,49507,-0.079748379751653,0.0217916527228881,-0.122460019088514,-0.0370367404147924,0.000253131679873038
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1568.Average weekly red wine intake,42604,-0.1505709797984,0.0251529803136775,-0.199870821213208,-0.101271138383593,2.187014855661e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42598,-0.119925795710454,0.0259747402458639,-0.170836286592347,-0.0690153048285608,3.91881566740077e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,42643,0.0266691867257828,0.0282935216038808,-0.0287861156178236,0.0821244890693893,0.34590284927227
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1598.Average weekly spirits intake,42563,0.00702460094428679,0.0281057652769235,-0.0480626989984832,0.0621119008870568,0.802640732515395
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1608.Average weekly fortified wine intake,42633,-0.0455156550558241,0.052514218248071,-0.148443522822043,0.0574122127103951,0.386100972361094
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1737.Childhood sunburn occasions,45113,-0.0478787186576237,0.0246956314086969,-0.0962821562186697,0.000524718903422192,0.0525446970723271
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1807.Father's age at death,40310,-0.0104275655069782,0.0047015812881002,-0.0196426648316546,-0.00121246618230183,0.0265762982075213
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1845.Mother's age,39624,-0.0210153594507668,0.00709356393790327,-0.0349187447690572,-0.0071119741324764,0.00305512692721135
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1873.Number of full brothers,50989,-0.00164692185678134,0.0205440551232848,-0.0419132698984195,0.0386194261848568,0.936106320598385
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1883.Number of full sisters,50990,0.0373646591238623,0.0204795844707736,-0.00277532643885394,0.0775046446865785,0.0680900373850822
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20015.Sitting height,51250,0.00192155662129239,0.00444176699425081,-0.00678430668743919,0.010627419930024,0.665300907447552
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20016.Fluid intelligence score,32568,0.0204136033478752,0.0353389440662369,-0.0488507270219491,0.0896779337176994,0.563514207845483
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20018.Prospective memory result,32890,-0.0390913792561705,0.0496487952676906,-0.136403017980844,0.0582202594685031,0.43109295641151
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32478,-0.00673838983588633,0.00611070769772821,-0.0187153769234336,0.00523859725166097,0.270180264676945
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32476,-0.00421114745157211,0.00605094496736502,-0.0160709995876075,0.00764870468446332,0.486479711448025
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20023.Mean time to correctly identify matches,51176,0.00148206637904487,0.00352818500375589,-0.00543317622831666,0.00839730898640641,0.674441409687875
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48308,-0.0115197005367814,0.00760504523449859,-0.0264255891963986,0.00338618812283582,0.129850044891739
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47885,-0.0171924294661207,0.0173091109258141,-0.0511182868807163,0.016733427948475,0.320593776809178
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47850,0.0428360355835844,0.0232383080292623,-0.00271104815376961,0.0883831193209384,0.0652921330251226
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47881,-0.0102215011035263,0.0177895593318748,-0.045089037394001,0.0246460351869483,0.565581670948196
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47882,-0.0126133443974233,0.0129438764137607,-0.0379833421683942,0.0127566533735477,0.329835910085827
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48048,-0.0166807498107354,0.00998419620247587,-0.0362497743675881,0.00288827474611734,0.0947908537006211
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,47981,0.0130827428591629,0.0129935027955037,-0.0123845226200243,0.03855000833835,0.314008286220565
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47885,0.00829192770770137,0.0156727449801074,-0.0224266524533092,0.0390105078687119,0.596764057957916
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48010,0.0219676311489974,0.0124009004621683,-0.00233813375685251,0.0462733960548473,0.0764977583047807
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48162,-0.0214118113616562,0.00786318858378556,-0.0368236609858759,-0.00599996173743647,0.00647295320389851
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48012,-0.0115618676640353,0.0107276349330458,-0.0325880321328051,0.00946429680473454,0.281149481765324
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49340,0.0231652835071615,0.00915918964701109,0.00521327179901979,0.0411172952153033,0.0114387603663978
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49213,-0.0150085810446345,0.0147966214128134,-0.0440099590137488,0.0139927969244797,0.310437441861564
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49159,0.00431494171734744,0.0308170923010863,-0.0560865591927817,0.0647164426274765,0.888647034764512
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49204,0.00786265082198691,0.0133067936201219,-0.018218664673452,0.0339439663174259,0.554609490231845
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49287,0.0216591080677702,0.0108292865288651,0.000433706471194516,0.0428845096643458,0.0455055461093586
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49210,0.0321683206684412,0.0175996043624869,-0.00232690388203315,0.0666635452189157,0.0675933357907202
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49186,0.00312320845775497,0.0167805608972257,-0.0297666909008074,0.0360131078163173,0.852351659867787
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49221,-0.0129958321465066,0.012657494205243,-0.0378045207887828,0.0118128564957696,0.304557295137732
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49225,0.0413556204397478,0.0148793226538539,0.0121921480381941,0.0705190928413015,0.00544991517669648
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49437,0.0082728221651092,0.00718628704310433,-0.00581230043937528,0.0223579447695937,0.24966252834628
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49276,0.0197553798291089,0.0111297255475878,-0.00205888224416318,0.041569641902381,0.0759081173007848
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46537,0.0121033019188778,0.0146341773618925,-0.0165796857104316,0.0407862895481872,0.408213337525727
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46425,-0.0235075769281643,0.080971133745117,-0.182210999068594,0.135195845212265,0.771573754355585
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46423,-0.113745459176319,0.0703700309512337,-0.251670719840738,0.0241798014880986,0.106023861668965
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46510,0.0205992423651245,0.0134114053821516,-0.00568711218389261,0.0468855969141416,0.124564716554655
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46430,0.0354161704491165,0.04545494291469,-0.053675517663676,0.124507858561909,0.435900154858152
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46443,0.0368198713142462,0.0252669622007397,-0.0127033745992036,0.086343117227696,0.145065758116142
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46432,-0.00545556282889936,0.0340826789897302,-0.0722576136487706,0.0613464879909719,0.872828557788574
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46440,-0.0154929934536598,0.0303977463297699,-0.0750725762600087,0.0440865893526892,0.610283642268939
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46445,-0.0195269660749202,0.0202453933615413,-0.0592079370635411,0.0201540049137006,0.334798601545732
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46449,0.0273113505235887,0.0267169411287723,-0.0250538540888051,0.0796765551359825,0.306674292274278
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46630,-0.0223000155252834,0.00942853634847808,-0.0407799467683004,-0.00382008428226638,0.01803052122832
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46521,-0.0130579331656328,0.013793249011979,-0.0400927012291117,0.0139768348978461,0.343806778546436
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20127.Neuroticism score,46029,0.0173617345413848,0.0214222697707192,-0.0246259142092248,0.0593493832919944,0.417688792915176
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32568,0.0352842176381184,0.0357540599953098,-0.0347937399526889,0.105362175228926,0.323739195801296
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20161.Pack years of smoking,31466,0.119703756803883,0.00796326101336557,0.104095765217686,0.135311748390079,2.38376016448357e-50
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31466,0.115256125161564,0.00744096510699962,0.100671833551845,0.129840416771283,2.65045382092534e-53
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20191.Fluid intelligence score,31219,0.013431493658135,0.03874049794756,-0.0624998823190826,0.0893628696353527,0.728823477814694
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31219,0.00140011585743556,0.0397723843455056,-0.0765537574597554,0.0793539891746265,0.971918653757519
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20240.Maximum digits remembered correctly,30587,0.00317265335427452,0.0410231282198283,-0.0772326779565889,0.083577984665138,0.938356835342284
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20255.Spirometry QC measure,44531,-0.0398123623672364,0.0276220962018108,-0.0939516709227856,0.0143269461883129,0.149508601016635
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20261.avMSE,29807,0.00243528503322179,0.00763744275125826,-0.0125341027592444,0.017404672825688,0.749842879176303
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20262.Myopia diagnosis,29807,0.0161420898916152,0.0515685118764527,-0.0849321933862321,0.117216373169463,0.754274761762787
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20280.Glucose-lactate,39438,-0.00845853748452837,0.0045396157997118,-0.0173561844519635,0.000439109482906751,0.0624428584001797
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39473,0.00425049445274713,0.00448672203075319,-0.00454348072752913,0.0130444696330234,0.343475311062582
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32460,0.0127241081962265,0.0218212340946281,-0.0300455106292445,0.0554937270216976,0.559836751181522
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32457,-0.0335598393658852,0.0435649796886111,-0.118947199555563,0.0518275208237927,0.441119498952528
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32455,0.0150334989996205,0.0481024566793711,-0.0792473160919468,0.109314314091188,0.754644745693223
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32455,0.0198116913913299,0.0210430865221605,-0.0214327581921047,0.0610561409747645,0.346484266820668
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32455,-0.0521390714700551,0.0341239644185606,-0.119022041730434,0.0147438987903236,0.126566407248117
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32462,0.0602961335516078,0.0433507758444268,-0.0246713871034687,0.145263654206684,0.164294951476157
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32462,-0.0200351992817193,0.0289244474230787,-0.0767271162309536,0.036656717667515,0.488533149141014
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32462,0.00826083487817145,0.0315258932865231,-0.0535299159634139,0.0700515857197568,0.793302018369455
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32462,0.0960752588374814,0.0482491248455162,0.00150697414026954,0.190643543534693,0.0464868322891956
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32462,0.112286435546269,0.0559949311038486,0.00253637058272549,0.222036500509812,0.0449626338391058
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32462,0.0147561130319446,0.0324801132691081,-0.0489049089755073,0.0784171350393965,0.649615570191984
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32462,0.115543104827718,0.0544076278022525,0.00890415433530281,0.222182055320132,0.0337273490255079
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32462,0.0546522130131794,0.0419019621869318,-0.027475632873207,0.136780058899566,0.192170411624439
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32465,0.0858587892090701,0.0567791385502325,-0.0254283223493856,0.197145900767526,0.130531467604997
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32465,0.0401106611488408,0.0280385556497163,-0.0148449079246032,0.0950662302222848,0.152594458961292
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32465,0.00719493968334073,0.0389502842559956,-0.0691476174584107,0.0835374968250922,0.853452142048743
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32465,-0.0722911871167184,0.0646573717894917,-0.199019635824122,0.0544372615906853,0.263570163709589
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20600.Liking for adding salt to foods,35118,-0.0174189760284513,0.0316555907189594,-0.0794639338376117,0.0446259817807092,0.582148283802207
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20601.Liking for aniseed,35118,0.058317870504686,0.0314886635721982,-0.0033999100968225,0.120035651106194,0.0640480581021318
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20602.Liking for apple juice,35118,0.0255180356572043,0.0314000770740544,-0.0360261154079424,0.0870621867223511,0.41642201807826
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20603.Liking for apples,35118,-0.0323231762265829,0.0320119804720104,-0.0950666579517232,0.0304203054985574,0.312650587230369
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20604.Liking for asparagus,35118,-0.097757789437689,0.0320451340129943,-0.160566252103158,-0.0349493267722202,0.00228894896039995
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20605.Liking for aubergine,35118,-0.114854414694479,0.0316653046698843,-0.176918411847452,-0.0527904175415058,0.000287848587790709
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20606.Liking for avocados,35118,-0.0775045880698437,0.0318833867442429,-0.13999602608856,-0.0150131500511276,0.0150778508528217
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20607.Liking for bacon,35118,-0.00951915359755231,0.0318830334801815,-0.0720098992187081,0.0529715920236035,0.765277591446796
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20608.Liking for baked or steamed fish,35118,-0.0108348823547752,0.0321501749737619,-0.0738492253033486,0.0521794605937982,0.736116777067769
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20609.Liking for bananas,35118,0.032769485683126,0.0324375310176183,-0.0308080751114059,0.096347046477658,0.312405085129308
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35118,-0.0616357131662126,0.0318591695529884,-0.12407968549007,0.000808259157644715,0.0530607274259297
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20611.Liking for beef steak,35118,-0.0495054711008774,0.0318884929422305,-0.112006917267649,0.0129959750658944,0.120581368018138
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20612.Liking for beetroot,35118,0.0616168262635505,0.0319983943045456,-0.00110002657335884,0.12433367910046,0.0541767109358477
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20613.Liking for bell pepper,35118,-0.0614129146431562,0.0318407740218138,-0.123820831725911,0.000995002439598866,0.0537869512826611
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20614.Liking for bicycling,35118,-0.0660909301219132,0.0314407104493879,-0.127714722602713,-0.00446713764111293,0.0355683259368512
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20615.Liking for biscuits,35118,-0.0316433166165359,0.0315824436386335,-0.0935449061482574,0.0302582729151857,0.316400194437488
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20616.Liking for bitter foods,35118,-0.0333092279925698,0.0315418345069782,-0.095131223626247,0.0285127676411074,0.290975674393614
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20617.Liking for bitter or ale,35118,0.024830127810587,0.0320421760810095,-0.0379725373081916,0.0876327929293655,0.438403134421835
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20618.Liking for black olives,35118,-0.0445863690998232,0.0317529885330021,-0.106822226624507,0.017649488424861,0.160297948541368
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20619.Liking for black pepper,35118,-0.0250101371159403,0.0319563163098173,-0.0876445170831821,0.0376242428513016,0.433857855748962
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20620.Liking for blue cheese,35118,-0.0727322140240918,0.0316998059789066,-0.134863833742749,-0.0106005943054349,0.0217855418867251
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20621.Liking for bolognese sauce,35118,-0.033305195246441,0.0318103957869508,-0.0956535709888646,0.0290431804959826,0.295126265905715
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20622.Liking for broad beans,35118,-0.00616050487789317,0.0314856871936316,-0.0678724517774111,0.0555514420216248,0.844879447672263
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20623.Liking for broccoli,35118,-0.0113705673338272,0.0325139547913961,-0.0750979187249635,0.0523567840573091,0.726560304704655
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20624.Liking for brown rice,35118,-0.0364501073778768,0.0317317423698875,-0.0986443224228563,0.0257441076671028,0.2507060165261
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20625.Liking for brussel sprouts,35118,0.0530581305078651,0.0318885880364456,-0.00944350204356824,0.115559763059298,0.0961683616372453
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20626.Liking for burgers (meat),35118,-0.023137530712587,0.0315413207610288,-0.0849585194042034,0.0386834579790294,0.463230698793231
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20627.Liking for burn of spicy foods,35118,-0.063554982132603,0.0315203088896855,-0.125334787556386,-0.00177517670881942,0.0437904029217688
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20628.Liking for butter on bread,35118,0.0112546374038735,0.0320780609913976,-0.0516183621392659,0.0741276369470129,0.725706291579653
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20629.Liking for butternut squash,35118,-0.0620646447763469,0.0316749611340512,-0.124147568599087,1.82790463934962e-05,0.0500879388910391
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20630.Liking for cabbage,35118,0.058853441407211,0.0318342315479124,-0.00354165242669732,0.121248535241119,0.0645205705452678
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20631.Liking for cake,35118,-0.0141368110755357,0.0317715669334245,-0.0764090822650478,0.0481354601139763,0.656363257947178
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20632.Liking for cake icing,35118,0.0720168797283774,0.0314653637121604,0.0103447668525431,0.133688992604212,0.022111355027298
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20633.Liking for capers,35118,-0.0811627799689529,0.0316657200710383,-0.143227591308188,-0.019097968629718,0.010386751605272
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20634.Liking for cauliflower,35118,0.0415499739809072,0.0322623359199884,-0.0216842044222701,0.104784152384084,0.197814697156763
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20635.Liking for cereal or granola bar,35118,-0.0218182442288827,0.0313363764008395,-0.0832375419745282,0.0396010535167628,0.486280827581767
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20636.Liking for cheesecake,35118,0.0377691198948274,0.0316009284467997,-0.0241686998609,0.0997069396505548,0.232037924059028
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20637.Liking for cherries,35118,-0.0345557544079064,0.0329296398456753,-0.09909784850543,0.0299863396896172,0.294025119734585
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20638.Liking for chicken,35118,0.0100730221810841,0.0332419408058328,-0.0550811817983483,0.0752272261605165,0.761879093553531
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20639.Liking for chilli pepper,35118,-0.051701631164586,0.0315799047163586,-0.113598244408649,0.010194982079477,0.101623199253071
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20640.Liking for chips or french fries,35118,0.00079462720002098,0.0316974910986059,-0.0613324553532465,0.0629217097532885,0.980000301142333
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20641.Liking for cigarette smoking,35118,0.085692760610026,0.0471264440108768,-0.00667506965129241,0.178060590871344,0.0690359693867309
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20642.Liking for cod,35118,0.00602884206222145,0.0325023331300736,-0.0576757308727227,0.0697334149971656,0.852848446360718
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20643.Liking for coffee with sugar,35118,0.0686575754883276,0.0344221534589641,0.00119015470875806,0.136124996267897,0.0461133146109833
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20644.Liking for coffee without sugar,35118,-0.0666714785384125,0.0318848780347485,-0.12916583948652,-0.00417711759030536,0.036549886517621
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20645.Liking for coriander,35118,-0.0285648650194068,0.031624357340035,-0.0905486054058755,0.0334188753670618,0.366409812124714
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20646.Liking for corn flakes,35118,0.102152452011434,0.0314206333893093,0.0405680105683876,0.16373689345448,0.00115287017972197
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20647.Liking for cream,35118,0.0383989876412649,0.0313841653254238,-0.0231139763965659,0.0999119516790956,0.221160983215444
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20648.Liking for croissant,35118,-0.0280657516854345,0.0315385887031552,-0.0898813855436186,0.0337498821727497,0.373546078922815
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20649.Liking for cucumber,35118,-0.000207341540949878,0.0319393359791331,-0.0628084400600508,0.062393756978151,0.994820500470289
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20650.Liking for curry,35118,-0.0115889955217886,0.0321083628082588,-0.0745213866259758,0.0513433955823986,0.718155663900782
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20651.Liking for dairy products,35118,-0.00897568501570847,0.0320536526027598,-0.0718008441171177,0.0538494740857007,0.779466801755532
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20652.Liking for dark chocolate,35118,0.0283737429385625,0.031879430159927,-0.0341099401748944,0.0908574260520194,0.373467233015739
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35118,-0.0486659148824633,0.0321677469360002,-0.111714698877024,0.014382869112097,0.130338441856305
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20654.Liking for dried fruit,35118,-0.0164286654301814,0.0316258881405234,-0.0784154061856074,0.0455580753252445,0.603444013158136
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20655.Liking for eggs,35118,0.00335557273685856,0.0327637435196822,-0.0608613645617185,0.0675725100354356,0.918427312204265
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20656.Liking for exercising alone,35118,-0.0282544717397536,0.0317043892642444,-0.0903950746976726,0.0338861312181654,0.372849065406814
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20657.Liking for exercising with others,35118,-0.0168706668295353,0.0314561094405252,-0.0785246413329647,0.0447833076738941,0.591745243172002
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35118,-0.00608255909911225,0.0322127329403809,-0.0692195156622589,0.0570543974640344,0.850233631654929
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20659.Liking for fatty foods,35118,-0.021099307981025,0.0315663279724674,-0.0829693108070611,0.0407706948450111,0.503884441988321
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20660.Liking for fresh tomatoes,35118,0.0370219354932395,0.0338734724533849,-0.0293700705153949,0.103413941501874,0.27444014644854
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20661.Liking for fried chicken,35118,-0.0282545254978486,0.0313451768132211,-0.0896910720517618,0.0331820210560647,0.367395266044746
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20662.Liking for fried or battered fish,35118,0.0127004084861481,0.0315256732080413,-0.0490899110016129,0.0744907279739091,0.687059439935442
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20663.Liking for fruit,35118,-0.0196236135721387,0.034333850702332,-0.0869179609487094,0.0476707338044321,0.567636299377318
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20664.Liking for garlic,35118,-0.0140763240584065,0.0322203288402063,-0.0772281685852109,0.049075520468398,0.662208860735889
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20665.Liking for gherkins,35118,-0.0417424337444784,0.0315417911245433,-0.103564344348583,0.0200794768596265,0.185728999539661
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20666.Liking for globe artichoke,35118,-0.123301808884324,0.0315444124318562,-0.185128857250762,-0.0614747605178854,9.32873556441934e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20667.Liking for goat's cheese,35118,-0.0706196163312461,0.0317002496354366,-0.132752105616702,-0.00848712704579038,0.0259181848657341
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20668.Liking for going to a cafe,35118,0.0148540289384305,0.0318487252063244,-0.0475694724659653,0.0772775303428264,0.640943107720109
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20669.Liking for going to the gym,35118,-0.0596179155415208,0.0313134013907529,-0.120992182267397,0.00175635118435492,0.0569473249871064
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20670.Liking for going to the pub,35118,-0.0284783120792973,0.031678403839335,-0.0905679836043939,0.0336113594457993,0.368681537080257
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20671.Liking for grapefruit,35118,-0.0842326650864392,0.0314471369442816,-0.145869053497231,-0.0225962766756473,0.00740496170932966
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20672.Liking for green olives,35118,-0.0554945871368371,0.0318299246360731,-0.11788123942354,0.00689206514986614,0.0812784942036059
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20673.Liking for haddock,35118,-0.013553105002957,0.032231167762925,-0.07672619381829,0.0496199838123761,0.67413055127677
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20674.Liking for ham,35118,-0.0328287020899922,0.0317302584976959,-0.0950200087454761,0.0293626045654917,0.30086950446975
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20675.Liking for hard cheese,35118,0.0388784661563432,0.0323669506983292,-0.024560757212382,0.102317689525068,0.229707486815756
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20676.Liking for herring,35118,0.0446745805552576,0.0314047729377433,-0.0168787744027193,0.106227935513234,0.154896954459193
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20677.Liking for honey,35118,0.00899092579004602,0.031574609996478,-0.0528953098030508,0.0708771613831428,0.775839573928584
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35118,-0.0265487103904265,0.0314203872001813,-0.0881326693027818,0.0350352485219288,0.398155762849315
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20679.Liking for ice cream,35118,-0.0190455980774299,0.0318371685439607,-0.0814464484235929,0.0433552522687331,0.549705881256645
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20680.Liking for jam,35118,0.0265340033731084,0.0318281503368772,-0.0358491712871708,0.0889171780333876,0.4044876924067
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20681.Liking for kiwi fruit,35118,0.0353290606010317,0.0316978823604769,-0.0267987888255031,0.0974569100275664,0.265064605225835
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20682.Liking for lager,35118,0.00636899592606186,0.0318626169059442,-0.0560817332095889,0.0688197250617126,0.841570778576236
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20683.Liking for lamb,35118,-0.0634925464134804,0.0319026425723444,-0.126021725855275,-0.000963366971685406,0.0465933913463285
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20684.Liking for lemons,35118,-0.0119767870302458,0.0319895174182166,-0.0746762411699503,0.0507226671094587,0.708115853144586
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20685.Liking for lentils or beans,35118,-0.0186677914627252,0.0317840942504058,-0.0809646161935205,0.0436290332680702,0.556993052559688
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20686.Liking for liver,35118,0.0519407852398047,0.0318107644833377,-0.0104083131475372,0.114289883627146,0.102537937260705
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20687.Liking for mackerel,35118,0.0113756004747678,0.0317033060717655,-0.0507628794258926,0.0735140803754282,0.719740726978071
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20688.Liking for marzipan,35118,0.0225426640399449,0.0315309765481376,-0.0392580499944049,0.0843433780742947,0.474662765270882
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20689.Liking for mayonnaise,35118,-0.0549603888052222,0.0314429062221811,-0.116588485000697,0.00666770739025279,0.0805012841832872
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20690.Liking for melon,35118,-0.0067439298537781,0.0323653421775192,-0.0701800005217156,0.0566921408141594,0.834944731596186
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20691.Liking for milk chocolate,35118,-0.0274473370054053,0.0318191869842946,-0.0898129434946226,0.0349182694838121,0.388373981820299
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20692.Liking for mushrooms,35118,0.0117392145351892,0.0326619036543737,-0.0522781166273832,0.0757565456977616,0.719290567046341
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20694.Liking for orange juice,35118,0.0712829010850653,0.0317719527739978,0.00900987364802962,0.133555928522101,0.0248788483995485
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20695.Liking for oranges,35118,-0.0205889605497381,0.0320835059336035,-0.083472632179601,0.0422947110801249,0.521061333938853
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20696.Liking for pasta,35118,-0.0143672586568304,0.0320925719989953,-0.0772686997748611,0.0485341824612003,0.654391518341474
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20697.Liking for pears,35118,0.0359540910487973,0.0319465250843506,-0.0266610981165298,0.0985692802141244,0.260424070152277
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20698.Liking for pizza,35118,0.0104460367821838,0.0316340081099248,-0.0515566191132687,0.0724486926776364,0.741243357349762
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20699.Liking for plain yogurt,35118,-0.0197508567208138,0.0316062910271235,-0.0816991871339758,0.0421974736923482,0.532047592626399
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20700.Liking for plums,35118,0.0151840545514064,0.0323009836622772,-0.0481258734266568,0.0784939825294697,0.638306795164124
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20701.Liking for pollock,35118,-0.0187904034093279,0.0315328712918401,-0.0805948311413345,0.0430140243226786,0.551254755472454
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20702.Liking for pork chop,35118,-0.0540795369914431,0.0315370929847257,-0.115892239241505,0.00773316525861932,0.0864110147296769
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20703.Liking for porridge,35118,0.0025648180361725,0.0319273116201541,-0.0600127127393295,0.0651423488116745,0.935973809187261
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20704.Liking for potato crisps,35118,-0.0415640761082228,0.0317331715650246,-0.103761092375671,0.0206329401592255,0.190290592400914
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20705.Liking for potatoes,35118,-0.0122008390781505,0.0319104155494658,-0.0747452535551036,0.0503435753988025,0.702211511948062
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20706.Liking for prawns,35118,-0.0254654449010577,0.0321732100355625,-0.0885249365707603,0.0375940467686449,0.42866263460581
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20707.Liking for raw carrots,35118,-0.0139414207759626,0.0320207066418805,-0.0767020057940483,0.0488191642421232,0.663289413818228
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20708.Liking for red meat,35118,-0.0386928024429244,0.0319056150428407,-0.101227807926892,0.0238422030410434,0.225259661007786
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20709.Liking for red wine,35118,-0.0751116183508991,0.0318280061714111,-0.137494510446865,-0.0127287262549334,0.0182957466005963
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35118,0.000841103488412848,0.032670941593281,-0.0631939420344179,0.0648761490112436,0.979461429356014
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20711.Liking for roast chicken,35118,-0.018340842742447,0.033219408168204,-0.0834508827521269,0.0467691972672329,0.580882406626946
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20712.Liking for salad dressing,35118,-0.0461711528557665,0.0315610953345635,-0.108030899711511,0.015688593999978,0.143518984315067
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20713.Liking for salad leaves,35118,-0.0462265265830027,0.0324019987392964,-0.109734444112024,0.0172813909460182,0.153706643471029
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20714.Liking for salami,35118,-0.0805220995758675,0.0318069524950516,-0.142863726466169,-0.0181804726855663,0.0113682317765391
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20715.Liking for salmon,35118,-0.0288452313089761,0.0329880019971871,-0.0935017152234628,0.0358112526055106,0.381910504698835
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20716.Liking for salty foods,35118,-0.0560554641892126,0.0316069205533533,-0.118005028473785,0.0058941000953599,0.0761698479389313
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20717.Liking for salty pretzels,35118,-0.100679739108014,0.03173148036776,-0.162873440628824,-0.0384860375872048,0.00151348128089572
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20718.Liking for sardines,35118,0.0165221918846325,0.0314605835886143,-0.0451405519490515,0.0781849357183164,0.599474546304061
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20719.Liking for sausages (meat),35118,-0.032514847157452,0.031658977566481,-0.0945664431877548,0.0295367488728507,0.304426526024679
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20720.Liking for savoury biscuits,35118,-0.0267194454103907,0.0316507738820812,-0.0887549622192698,0.0353160713984884,0.398578041120799
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35118,-0.0155544354774131,0.0317390188741437,-0.0777629124707347,0.0466540415159085,0.624091816817634
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20722.Liking for skimmed milk,35118,0.0132222049744945,0.0313855997477255,-0.0482935705310474,0.0747379804800364,0.673556832199579
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20723.Liking for smoked fish,35118,-0.029956290154755,0.0317725260476033,-0.0922304412080575,0.0323178608985475,0.345784901180975
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20724.Liking for soft cheese,35118,0.00817678006543712,0.0316369825465726,-0.0538317057258452,0.0701852658567194,0.79605943573679
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20725.Liking for soy sauce,35118,0.00231000266528292,0.0317393360171867,-0.0598990959284029,0.0645191012589688,0.941982134644253
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20726.Liking for soya milk,35118,-0.0246378172081195,0.0318310313865765,-0.0870266387258094,0.0377510043095703,0.438935931076581
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20727.Liking for spicy foods,35118,0.00601760670217986,0.0317979316247288,-0.0563063392822886,0.0683415526866483,0.849904038363772
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20728.Liking for spinach,35118,-0.0698349919292633,0.0319464951533658,-0.13245012242986,-0.00721986142866644,0.0288362526631481
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20729.Liking for spirits,35118,-0.0550093127385204,0.0315476045235329,-0.116842617604645,0.00682399212760404,0.0812400891910392
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20730.Liking for strawberries,35118,-0.00398350296868118,0.0344286901165041,-0.0714637355970293,0.0634967296596669,0.90788998838999
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35118,0.0013471692734834,0.0323934517215512,-0.062143996100757,0.0648383346477238,0.96682811382813
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20732.Liking for sweet foods,35118,0.0189842887665361,0.0315072455737051,-0.0427699125579259,0.0807384900909981,0.546828728256696
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20733.Liking for taking the stairs,35118,-0.0359456716827633,0.0323601998958888,-0.0993716634787053,0.0274803201131787,0.266678698879392
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20734.Liking for tea with sugar,35118,0.0794589315613801,0.0374047802019671,0.00614556236552471,0.152772300757236,0.0336669121213735
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20735.Liking for tea without sugar,35118,-0.0979201124186369,0.0331785760030368,-0.162950121384589,-0.0328901034526849,0.00317086709341458
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20736.Liking for tomato ketchup,35118,-0.00383376063122571,0.0314671886866937,-0.0655094504571454,0.0578419291946939,0.90303298568456
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20737.Liking for tinned tuna,35118,-0.0314154339166397,0.0317336911299288,-0.0936134685313002,0.0307826006980207,0.32220958740529
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20738.Liking for turnip (white),35118,0.0620064310711513,0.0317369280131627,-0.000197947834647556,0.12421080997695,0.0507540178571333
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20739.Liking for vegetables,35118,0.0259040579185284,0.0348231938766759,-0.0423494020797564,0.0941575179168132,0.456968427471782
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20740.Liking for vinegar,35118,-0.0297831320962528,0.0316259119069868,-0.0917699194339469,0.0322036552414413,0.346350109367612
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20741.Liking for watching television,35118,-0.0774885815277516,0.0317807224147346,-0.139778797460631,-0.0151983655948717,0.0147749155437137
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20742.Liking for whisky,35118,-0.0404477936913113,0.0327503980930231,-0.104638573953636,0.023742986571014,0.216844343888955
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20743.Liking for white bread,35118,0.0224529702545158,0.0315282867267685,-0.0393424717299505,0.0842484122389821,0.476384683695517
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20744.Liking for white rice,35118,0.0310616343864395,0.0316699048060048,-0.0310113790333298,0.0931346478062089,0.326715714507935
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20745.Liking for white wine,35118,-0.088943061471527,0.0314674138644045,-0.15061919264576,-0.0272669302972943,0.00471408040463652
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35118,-0.0522013407641072,0.0316600959064577,-0.114255128740764,0.00985244721254979,0.0992154086717601
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20747.Liking for whole milk,35118,0.0187605540930273,0.0313698714798579,-0.0427243940074941,0.0802455021935487,0.549822812691431
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20748.Liking for wholemeal bread,35118,-0.00500942344374602,0.0329198975532556,-0.069532422648127,0.059513575760635,0.879055520830848
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20749.Liking for working up a sweat,35118,-0.0155417731292134,0.0315305607476368,-0.0773416721945815,0.0462581259361547,0.6220848066031
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21001.Body mass index (BMI),51351,0.0552918400868443,0.0139761166678047,0.0278986514179471,0.0826850287557416,7.63532494275463e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21002.Weight,51372,-0.00985556629714996,0.00815525755969069,-0.0258398711141437,0.00612873851984378,0.2268683269181
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32803,0.0123133774090048,0.00634486659978284,-0.000122561126569538,0.0247493159445792,0.0523280731270884
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34494,-0.00952779296960412,0.0338988637539781,-0.0759695659274011,0.0569139799881929,0.778665816565157
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34494,0.0450249114560914,0.0350226065847208,-0.0236193974499614,0.113669220362144,0.198612210964132
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34494,0.0521250475268959,0.0347169608943937,-0.0159201958261159,0.120170290879908,0.133274369507225
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21040.Satisfaction with bowel habits,34466,0.00763698437901179,0.0322149911227088,-0.0555043982214975,0.0707783669795211,0.812612451742821
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34463,0.0048278361128442,0.0340705851767428,-0.0619505108335717,0.0716061830592601,0.887318876579025
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21042.Greatest number of times bowels opened per day,34453,0.0574006740844538,0.034926046301892,-0.0110543766672546,0.125855724836162,0.100310880520472
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21043.Least number of times bowels opened per week,34398,0.0212072133609193,0.0345278286551449,-0.0464673308031647,0.0888817575250034,0.539092204918
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21044.Average number of times bowels opened per day,34426,0.114174384222213,0.0385066171862946,0.0387014145370751,0.18964735390735,0.00303301741933142
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34499,-0.0185161862436842,0.0349380353744712,-0.0869947355776477,0.0499623630902793,0.596142290689529
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34494,-0.0290837902358083,0.0352072260950331,-0.0980899533820731,0.0399223729104565,0.408780389939425
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30088,0.0509256684531141,0.05139204598006,-0.0498027416678036,0.151654078574032,0.32176065618213
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34496,-0.01235056899676,0.0368826642427354,-0.0846405909125214,0.0599394529190014,0.737736482057565
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34494,-0.057669886522063,0.051974711378159,-0.159540320823255,0.0442005477791286,0.26720691968693
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34497,-0.0312516906812227,0.041404141588119,-0.112403808193936,0.0499004268314905,0.450387958225318
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34496,-0.0416227478996231,0.100741693809341,-0.239076467765931,0.155830971966684,0.679495470056057
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34497,-0.0547503288685708,0.0391864800234098,-0.131555829714454,0.0220551719773124,0.162390416027888
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34497,-0.10514482744632,0.0405921280071034,-0.184705398340243,-0.0255842565523975,0.00960297349384808
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34253,0.0484349230445518,0.0369269175876419,-0.0239418354272264,0.12081168151633,0.189669686745498
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34497,-0.0140757574616272,0.0364811222186322,-0.0855787570101464,0.057427242086892,0.699625296598284
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34498,-0.0118170754750266,0.0494975183004649,-0.108832211343938,0.0851980603938845,0.811311202441402
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34496,-0.058733629144499,0.0351305584472624,-0.127589523701133,0.0101222654121353,0.094579925615808
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34494,-0.00133273366630656,0.0349436653626174,-0.0698223177770367,0.0671568504444236,0.96957717966051
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X21100.Water hardness (USGS classification),51119,-0.0592803248884594,0.0208976040501178,-0.10023962882669,-0.0183210209502285,0.00456154020565662
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2139.Age first had sexual intercourse,48476,-0.00964060188768185,0.00375108023467091,-0.0169927191476368,-0.00228848462772686,0.0101731299570236
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2149.Lifetime number of sexual partners,46508,-0.0139518514315168,0.0237693662353529,-0.0605398092528084,0.0326361063897748,0.557231217095516
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22032.IPAQ activity group,46479,0.0011411619283882,0.022726672333999,-0.0434031158462498,0.0456854397030262,0.959953532732422
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22033.Summed days activity,47046,-0.00282251454992027,0.00361447771683336,-0.00990689087491366,0.00426186177507311,0.434874345509107
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22034.Summed minutes activity,46479,-0.00596859897070337,0.00368984573353092,-0.013200696608424,0.00126349866701723,0.105768353866253
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22037.MET minutes per week for walking,45719,0.00112901923171664,0.00361877325113403,-0.00596377634050607,0.00822181480393935,0.755051484205026
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22038.MET minutes per week for moderate activity,46479,-0.00277812019211889,0.00378449702090605,-0.0101957343530948,0.00463949396885698,0.46290813566091
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22039.MET minutes per week for vigorous activity,46479,-0.0452307203290979,0.0228129008912539,-0.0899440060759555,-0.000517434582240336,0.0474150773472755
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22040.Summed MET minutes per week for all activity,45719,-0.00284561610027235,0.00373004210343516,-0.0101564986230053,0.00446526642246057,0.445536548705159
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X2217.Age started wearing glasses or contact lenses,45868,-0.0053741129509682,0.00431983030992499,-0.0138409803584212,0.00309275445648478,0.213492021104586
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X22501.Year ended full time education,31211,-0.0433667352712239,0.0175495721439191,-0.0777638966733052,-0.00896957386914253,0.0134923438926897
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X22506.Tobacco smoking,31162,-0.234180605807768,0.074903553326344,-0.380991570327403,-0.0873696412881341,0.00177638479525514
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49471,-0.0452971314953958,0.044741056857585,-0.132989602936262,0.0423953399454708,0.311342670900053
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23098.Weight,51006,-0.0108438279143848,0.00821118354023919,-0.0269377476532536,0.005250091824484,0.186640261643921
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23099.Body fat percentage,50984,0.00887275540495248,0.00795635658786984,-0.00672170350727241,0.0244672143171774,0.264783946920343
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23100.Whole body fat mass,50948,0.00255544862650096,0.00756431306566349,-0.0122706049821995,0.0173815022352014,0.735494243250808
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23101.Whole body fat-free mass,51001,-0.0172618903846577,0.00700894375517863,-0.0309994201448079,-0.00352436062450763,0.0137903949955094
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23102.Whole body water mass,51006,-0.0171703428473116,0.007008183073346,-0.0309063816710697,-0.0034343040235534,0.0142902240626367
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23104.Body mass index (BMI),51006,0.0483665604437694,0.0140936562827435,0.0207429941295922,0.0759901267579465,0.000600490460766132
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23105.Basal metabolic rate,51004,-0.0183349312987193,0.00751423488567538,-0.033062831674643,-0.00360703092279554,0.0146925432305642
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23106.Impedance of whole body,51003,0.00249509071925552,0.00576631256895464,-0.00880688191589558,0.0137970633544066,0.665235251535921
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23107.Impedance of leg (right),51003,0.0222998918190658,0.00474942850704813,0.0129910119452515,0.0316087716928802,2.67543727510649e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23108.Impedance of leg (left),51002,0.0232295891814321,0.00471570499238592,0.0139868073963557,0.0324723709665085,8.44208679711437e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23109.Impedance of arm (right),50996,-0.0153393724991204,0.00578694047533301,-0.0266817758307731,-0.00399696916746765,0.00803746732446491
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23110.Impedance of arm (left),51001,-0.0174799996661519,0.00578052397659648,-0.028809826660281,-0.0061501726720228,0.00249733006881224
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23111.Leg fat percentage (right),51002,0.0423150611140748,0.00981266395482741,0.023082239762613,0.0615478824655365,1.62141383105639e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23112.Leg fat mass (right),51001,0.0186941181470073,0.0101898108419093,-0.00127791110313493,0.0386661473971495,0.066577501684947
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23113.Leg fat-free mass (right),51001,-0.0341713252130496,0.00753424851662949,-0.0489384523056434,-0.0194041981204558,5.77223654758393e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23114.Leg predicted mass (right),51000,-0.0329683472225945,0.00756193401913536,-0.0477897379000998,-0.0181469565450892,1.30673664684289e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23115.Leg fat percentage (left),50999,0.0421135809275635,0.0101504312524108,0.0222187356728384,0.0620084261822887,3.35027736530176e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23116.Leg fat mass (left),50999,0.0188456147840546,0.010596143648641,-0.0019228267672818,0.039614056335391,0.0753271828444667
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23117.Leg fat-free mass (left),50997,-0.035163116262962,0.00781574929075545,-0.0504819848728427,-0.0198442476530813,6.85545275290474e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23118.Leg predicted mass (left),50996,-0.0353199693862288,0.00784568187523668,-0.0506975058616927,-0.0199424329107649,6.76491935799224e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23119.Arm fat percentage (right),50996,-0.0107022422644027,0.0087478428061253,-0.0278480141644083,0.00644352963560284,0.221183607298726
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23120.Arm fat mass (right),50993,-9.68699399201245e-05,0.00856791778289356,-0.0168899887943915,0.0166962489145513,0.990979293615902
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23121.Arm fat-free mass (right),50993,-0.000796348492431208,0.00701433555514438,-0.0145444461805142,0.0129517491956518,0.909609979628919
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23122.Arm predicted mass (right),50992,-0.00218675424786211,0.00701918448043858,-0.0159443558295217,0.0115708473337975,0.755392801918046
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23123.Arm fat percentage (left),50988,-0.0130141658661442,0.00896434568992796,-0.030584283418403,0.00455595168611457,0.14657720304484
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23124.Arm fat mass (left),50987,-0.00400624208014418,0.00853179367110974,-0.0207285576755193,0.0127160735152309,0.638668739779051
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23125.Arm fat-free mass (left),50983,-0.00186912576760203,0.00712691112375784,-0.0158378715701674,0.0120996200349633,0.793120604252363
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23126.Arm predicted mass (left),50982,0.000557989168992128,0.00716267800426245,-0.0134808597193623,0.0145968380573465,0.937906335809371
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23127.Trunk fat percentage,50979,0.00221841212654152,0.00571140737552238,-0.00897594632948235,0.0134127705825654,0.697709943720498
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23128.Trunk fat mass,50975,-0.0029520410063553,0.00622442979814909,-0.0151519234107275,0.00924784139801691,0.635313413241496
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23129.Trunk fat-free mass,50969,-0.00969872706688877,0.00638252055084202,-0.0222084673465391,0.00281101321276158,0.128629156257992
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23130.Trunk predicted mass,50967,-0.0110408633030374,0.00637148973356095,-0.0235289831808168,0.00144725657474209,0.0831329439680584
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23400.Total Cholesterol,39477,0.0269410660154658,0.00478323610837789,0.0175659232430451,0.0363162087878864,1.80789603472305e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39477,0.0426060901152991,0.00463634715223375,0.033518849696921,0.0516933305336773,4.43071452427172e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39477,0.0487356270903261,0.00465438038357452,0.03961304153852,0.0578582126421322,1.42802217493665e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23403.VLDL Cholesterol,39477,0.0587778915606338,0.0045802073017233,0.0498006852492561,0.0677550978720115,1.65702238163418e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39477,0.0346343695119218,0.00463630565171138,0.0255472104345675,0.0437215285892761,8.42720569262186e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23405.LDL Cholesterol,39477,0.0353928779058246,0.00459633622935632,0.0263840588962862,0.044401696915363,1.43927097906924e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23406.HDL Cholesterol,39477,-0.0494009320213078,0.00524767501152419,-0.0596863750438952,-0.0391154889987204,5.43530868187682e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23407.Total Triglycerides,39477,0.0507373368534121,0.00470765082746219,0.0415103412315862,0.059964332475238,5.46313474033847e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23408.Triglycerides in VLDL,39477,0.0513514813226796,0.00478375811874329,0.0419753154099427,0.0607276472354164,8.68814459234134e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23409.Triglycerides in LDL,39477,0.047871450982952,0.00449735424108805,0.0390566366704195,0.0566862652954846,2.28115643883242e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23410.Triglycerides in HDL,39477,0.0315301313251638,0.00445603234935675,0.0227963079204245,0.040263954729903,1.54870777139781e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39477,0.0189054259517713,0.00474221461921928,0.00961068529810156,0.0282001666054411,6.73250353258058e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23412.Phospholipids in VLDL,39477,0.0600081197328488,0.00463045375393875,0.0509324303751288,0.0690838090905687,3.26993472585706e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23413.Phospholipids in LDL,39477,0.0381138054083885,0.00459947642002369,0.0290988316251421,0.0471287791916349,1.25964213967608e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23414.Phospholipids in HDL,39477,-0.0356784858314328,0.00493669691297228,-0.0453544117808585,-0.0260025598820071,5.15875587694231e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23415.Total Esterified Cholesterol,39477,0.0229331021756533,0.00480186500266244,0.013521446770435,0.0323447575808717,1.80552915052315e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39477,0.0573560981108755,0.00458129900442207,0.0483767520622082,0.0663354441595428,8.66220127141843e-36
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39477,0.0377961854784472,0.00457779155597718,0.0288237140287319,0.0467686569281624,1.62009492822047e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39477,-0.0536295040963001,0.00523514895406361,-0.0638903960462648,-0.0433686121463355,1.50389949090149e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23419.Total Free Cholesterol,39477,0.0361366524963048,0.0047329213823975,0.0268601265868057,0.0454131784058039,2.38542610247418e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39477,0.0593835534911263,0.00460633659337389,0.0503551337681135,0.0684119732141392,7.81598922780451e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23421.Free Cholesterol in LDL,39477,0.0278011445522799,0.00465725351779356,0.0186729276574045,0.0369293614471553,2.43240676839893e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23422.Free Cholesterol in HDL,39477,-0.0317742936466402,0.00521242622913226,-0.0419906490557394,-0.021557938237541,1.11400744224102e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39477,0.0351720787643152,0.00461495369225549,0.0261267695274945,0.044217388001136,2.65464275218563e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23424.Total Lipids in VLDL,39477,0.0577897151974806,0.00467599689154002,0.0486247612900621,0.066954669104899,6.35848925177464e-35
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23425.Total Lipids in LDL,39477,0.0380431237519932,0.00458982717036032,0.029047062498087,0.0470391850058995,1.23851523218036e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23426.Total Lipids in HDL,39477,-0.0384117476241404,0.00504381030076245,-0.0482976158136348,-0.028525879434646,2.77418006210002e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39477,-0.0197409423102557,0.00475704899088805,-0.0290647583323962,-0.0104171262881151,3.34485831434497e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23428.Concentration of VLDL Particles,39477,0.0596062213899851,0.00457007138125271,0.0506488814827298,0.0685635612972405,1.11325619364632e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23429.Concentration of LDL Particles,39477,0.0495921530077585,0.00459486910472029,0.0405862095625068,0.0585980964530103,4.63094740416602e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23430.Concentration of HDL Particles,39477,-0.02967612902859,0.0047553397658235,-0.0389965949696041,-0.020355663087576,4.47167821866827e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39477,0.0416343576322846,0.0050349475809838,0.0317658603735563,0.0515028548910128,1.45779201936878e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39477,-0.0013101172189898,0.00460462744171678,-0.0103351870047547,0.00771495256677508,0.776014247451903
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39477,-0.0377510989703824,0.00534171251307743,-0.0482208554960141,-0.0272813424447506,1.64745595441183e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23434.Phosphoglycerides,39465,0.0078882927079432,0.00469286272783879,-0.00130971823862082,0.0170863036545072,0.0927998791137481
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39465,0.05812893392326,0.0050402427994436,0.0482500580363505,0.0680078098101694,1.19794350247755e-30
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23436.Total Cholines,39465,0.00763778641098046,0.0047714338342374,-0.00171422390412485,0.0169897967260858,0.10945655193147
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23437.Phosphatidylcholines,39465,0.00655235207348294,0.00476160173853001,-0.00278038733403589,0.0158850914810018,0.168816148757512
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23438.Sphingomyelins,39464,0.0119407595765142,0.00491675157252672,0.00230392649436186,0.0215775926586666,0.0151690038020187
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23439.Apolipoprotein B,39477,0.0512289816673876,0.00461011719194259,0.0421931519711801,0.0602648113635951,1.39904213740835e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23440.Apolipoprotein A1,39477,-0.0359633419248086,0.00490296602554877,-0.0455731553348842,-0.026353528514733,2.32578876875296e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39477,0.0628959550302866,0.00460501194216085,0.0538701316236514,0.0719217784369219,3.15562651805301e-42
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23442.Total Fatty Acids,39465,0.0352135047106889,0.00450004600198474,0.0263934145467988,0.044033594874579,5.3943514153169e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23443.Degree of Unsaturation,39465,-0.0408906177338503,0.00500256440886823,-0.050695643975232,-0.0310855914924686,3.21244780229636e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39465,0.00330003499235809,0.00458605760962826,-0.00568863792251329,0.0122887079072295,0.471794451885452
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39465,0.0260490107774544,0.00456822006543946,0.0170952994491931,0.0350027221057158,1.20395675096475e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39465,0.0233955569258596,0.00457033247823693,0.0144377052685152,0.032353408583204,3.1080158794923e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39465,0.0435020227432931,0.00457779512639717,0.0345295442955546,0.0524745011910315,2.33314559029635e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23448.Saturated Fatty Acids,39465,0.0342853204657041,0.00452425444588426,0.0254177817517709,0.0431528591796372,3.70260656511424e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23449.Linoleic Acid,39465,0.0312235772276971,0.00460101929186109,0.0222055794156494,0.0402415750397448,1.19245291107337e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23450.Docosahexaenoic Acid,39465,-0.0130790318193134,0.00479668311059947,-0.0224805307160883,-0.00367753292253844,0.00640460150254948
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39465,-0.0178640986145524,0.00464571621575482,-0.0269697023974318,-0.00875849483167294,0.00012089107908128
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39465,-0.0337323045908118,0.00471865564469528,-0.0429808696544146,-0.024483739527209,9.14792458370637e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39465,-0.042157750871905,0.004908944989982,-0.0517792830522698,-0.0325362186915403,9.68002286576835e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39465,0.050890523059911,0.00501063058011588,0.0410696871228839,0.0607113589969382,3.68516705364443e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39465,0.0123541963664445,0.00452338869523179,0.00348835452379015,0.0212200382090988,0.00631785691590171
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39465,-0.00691202356505502,0.00483938993677698,-0.0163972278411379,0.00257318071102786,0.153230123763839
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39465,-0.0369479839497947,0.00485461012808378,-0.0464630198008389,-0.0274329480987505,2.87701897570984e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39465,-0.0496666827618809,0.00500722470304419,-0.0594808431798475,-0.0398525223439142,4.02904684798225e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39463,0.00727164641490752,0.00460504022344938,-0.00175423242305327,0.0162975252528683,0.114341988779746
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23460.Alanine,39473,0.00506547838594745,0.00447331978423554,-0.00370222839115422,0.0138331851630491,0.257493928854585
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23461.Glutamine,39437,-0.000946000715900623,0.00442727175747897,-0.0096234533605594,0.00773145192875815,0.830802701759529
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23462.Glycine,39458,0.0165941331004422,0.00462890023869952,0.00752148863259113,0.0256667775682932,0.000338239874532884
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23463.Histidine,39459,-0.00128421846522405,0.00441542880141785,-0.00993845891600303,0.00737002198555494,0.771171469043312
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39465,-0.00644819569136467,0.00469942334322133,-0.0156590654440785,0.00276267406134914,0.17004428859959
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23465.Isoleucine,39475,-0.011120004984615,0.00458325112474694,-0.020103177189119,-0.002136832780111,0.0152679963098443
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23466.Leucine,39476,-0.0101991872654313,0.00472797350744976,-0.0194660153400328,-0.000932359190829764,0.0310052452257937
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23467.Valine,39465,-0.000751622926784837,0.00468019870857387,-0.00992481239558962,0.00842156654201995,0.872413392323393
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23468.Phenylalanine,39473,-0.00196361590702057,0.00445647130042135,-0.0106982996558464,0.00677106784180528,0.659493324387377
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23469.Tyrosine,39460,0.0017940939928371,0.00455086269895006,-0.00712559689710502,0.0107137848827792,0.693415428528378
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23470.Glucose,39449,-0.0166383805733802,0.00454972715221172,-0.0255558457917152,-0.00772091535504528,0.000256017957762129
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23471.Lactate,39449,0.0137444504709333,0.00447182178581895,0.00497967977072816,0.0225092211711384,0.00211880350213326
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23472.Pyruvate,39433,0.00585410424469762,0.00442802542594499,-0.00282482559015456,0.0145330340795498,0.186168420999111
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23473.Citrate,39476,-0.00771781426601166,0.00451758087326179,-0.0165722727776048,0.00113664424558146,0.0875828779284929
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23474.3-Hydroxybutyrate,39227,-0.00949542687686959,0.00439643884292531,-0.0181124470090032,-0.000878406744735969,0.0308036023884479
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23475.Acetate,39463,-0.0221686408834965,0.00446465425977715,-0.0309193632326597,-0.0134179185343333,6.92960090120006e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23476.Acetoacetate,39477,-0.0143973428332773,0.00437164748357138,-0.0229657719010772,-0.00582891376547736,0.000992230351655582
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23477.Acetone,39477,-0.0267335976684766,0.00440803876348693,-0.035373353644911,-0.0180938416920422,1.35215549412609e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23478.Creatinine,39064,0.026659723547483,0.0055355061604187,0.0158101314730623,0.0375093156219036,1.47778431421507e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23479.Albumin,39476,-0.0276630567809539,0.00453510833521666,-0.0365518691179785,-0.0187742444439292,1.0873480841771e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23480.Glycoprotein Acetyls,39477,0.0450284809276126,0.00473854237199666,0.0357409378784991,0.054316023976726,2.33806733827144e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39477,0.0436650673288153,0.00476072316160045,0.0343340499320784,0.0529960847255522,5.21491042752935e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39477,0.0420719331392508,0.00478379981945264,0.0326956854931236,0.051448180785378,1.5822876337444e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39477,0.0428733020432002,0.00478482197662595,0.0334950509690133,0.052251553117387,3.59876575949837e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39477,0.0473596146488319,0.00474921159118719,0.038051159930105,0.0566680693675588,2.37135084122901e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39477,0.0504753915621042,0.00476747299963938,0.041131144482811,0.0598196386413973,4.17744363998294e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39477,0.0423013733724641,0.00470996213269917,0.0330698475923737,0.0515328991525545,2.97736101592057e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39477,0.0370246206178834,0.00477477936621639,0.0276660530600993,0.0463831881756676,9.43608802559425e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39477,0.0557781991425376,0.00484243831451618,0.0462870200460858,0.0652693782389893,1.4127560058847e-30
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39477,0.0555384599902064,0.00484939752626784,0.0460336408387214,0.0650432791416913,3.01162182490502e-30
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39477,0.056712901557097,0.00481364304736234,0.0472781611842669,0.0661476419299272,6.6200717914337e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39477,0.0601780520852129,0.00473885858494743,0.0508898892587159,0.0694662149117099,9.11954155057667e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39477,0.0605662257891957,0.00469479515122455,0.0513644272927956,0.0697680242855958,6.96254313038827e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39477,0.0580679517473054,0.00477449623828759,0.0487099391202617,0.0674259643743491,7.03860880959536e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39477,0.0509616233379332,0.00489645036840535,0.0413645806158587,0.0605586660600077,2.76150425029765e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39477,0.056916572189552,0.00478932362863568,0.047529497877426,0.0663036465016779,1.97644821911068e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39477,0.0559483694492007,0.00479520414456355,0.0465497693258562,0.0653469695725453,2.51814805419172e-31
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39477,0.0583882665495074,0.00481905248824203,0.0489429236725531,0.0678336094264618,1.2281088301364e-33
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39477,0.0602254129588297,0.00470626067694233,0.0510011420320228,0.0694496838856367,2.62794012141782e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39477,0.0604784023690582,0.0046279384418003,0.0514076430231296,0.0695491617149868,8.00656896602873e-39
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39477,0.0588369393389691,0.00479529927421182,0.049438152761514,0.0682357259164243,1.89799436513695e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39477,0.0499924644126088,0.00482595745313047,0.0405335878044731,0.0594513410207446,4.58842361731857e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39477,0.0558300229943876,0.00457583743208772,0.0468613816274956,0.0647986643612795,4.38593865278198e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39477,0.0561809505152295,0.00459388377256495,0.0471769383210022,0.0651849627094568,3.10112815322942e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39477,0.0562414363100254,0.00457451626014732,0.0472753844401366,0.0652074881799141,1.40096393610663e-34
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39477,0.0484782684721007,0.00462490321804111,0.0394134581647401,0.0575430787794612,1.27109047648717e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39477,0.0418266030529575,0.00468552673507191,0.0326429706522166,0.0510102354536985,4.86638776289227e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39477,0.0543508281146841,0.00457337586704545,0.045387011415275,0.0633146448140931,1.97342447554134e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39477,0.0523218162053173,0.00471815235689598,0.0430742375858012,0.0615693948248334,1.80249442614933e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39477,0.0591408395145839,0.00459411757815741,0.0501363690613954,0.0681453099677724,9.91401798677303e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39477,0.0587293078713941,0.00458281640772903,0.0497469877122453,0.067711628030543,2.08264843873644e-37
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39477,0.0573441431173898,0.00455211728023484,0.0484219932481295,0.0662662929866501,3.27965799374009e-36
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39477,0.0576196737845961,0.00456025582111987,0.0486815723752012,0.066557775193991,2.03601159557992e-36
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39477,0.0593494379699591,0.00456739112170871,0.05039735137141,0.0683015245685081,2.0884435698025e-38
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39477,0.0536446774942958,0.00456387291768019,0.0446994865756426,0.062589868412949,9.14462041807218e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39477,0.0494266467698673,0.0046503827181255,0.0403118966423413,0.0585413968973933,2.70061297445872e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39477,0.0556204704928284,0.00458973424203005,0.0466245913784495,0.0646163496072073,1.19413691579604e-33
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39477,0.0546170613264648,0.0045777792954347,0.0456446139074128,0.0635895087455168,1.13263563930305e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39477,0.0568796768680348,0.00454953632032149,0.0479625856802047,0.0657967680558649,1.0748548318446e-35
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39477,0.0484877022130917,0.00475533079271669,0.039167253859367,0.0578081505668164,2.45013318190201e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39477,0.0449829912547544,0.00482193698253202,0.0355319947689917,0.0544339877405172,1.21133291472039e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39477,0.0544226739402068,0.00461221979766032,0.0453827231367925,0.063462624743621,5.35810070262342e-32
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39477,0.049104799315105,0.00451824983102881,0.0402490296462885,0.0579605689839215,2.05038789371983e-27
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23523.Concentration of IDL Particles,39477,0.0440675293423801,0.00472332166555577,0.0348098188778908,0.0533252398068694,1.20054721886608e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23524.Total Lipids in IDL,39477,0.0350588547774025,0.00483403716232004,0.0255841419392552,0.0445335676155498,4.28347169818183e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23525.Phospholipids in IDL,39477,0.0395458508873754,0.00483069483063173,0.0300776890193372,0.0490140127554136,2.89850828274199e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23526.Cholesterol in IDL,39477,0.0288366729529946,0.00486767573347098,0.0192960285153915,0.0383773173905977,3.20581013513027e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39477,0.0283619392641004,0.00486033228600156,0.0188356879835374,0.0378881905446635,5.47273765366021e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23528.Free Cholesterol in IDL,39477,0.029318865295496,0.00486825751990393,0.0197770805564843,0.0388606500345077,1.75642075710802e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23529.Triglycerides in IDL,39477,0.0475365044360947,0.00445675178930919,0.0388012709290487,0.0562717379431407,1.80737966618031e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39477,0.0484330079453572,0.00460297372531706,0.0394111794437358,0.0574548364469787,8.33528653199072e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23531.Total Lipids in Large LDL,39477,0.0343117347374731,0.00462785430494829,0.0252411402997745,0.0433823291751717,1.28656488876606e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23532.Phospholipids in Large LDL,39477,0.0336730705002158,0.00464431609779167,0.0245702109485441,0.0427759300518875,4.35073485932584e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23533.Cholesterol in Large LDL,39477,0.0316979049400327,0.0046370330392423,0.0226093201831178,0.0407864896969476,8.45592831346222e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39477,0.0335023872850805,0.00460946376381559,0.0244678383080019,0.0425369362621591,3.81624828398867e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39477,0.0259512035622728,0.00471927968845691,0.0167014153728972,0.0352009917516483,3.8799974681397e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23536.Triglycerides in Large LDL,39477,0.0465732620745724,0.00447119462842113,0.037809720602867,0.0553368035462778,2.52925749852854e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39477,0.0462312784104204,0.00457521326233534,0.0372638604162431,0.0551986964045976,6.23605772990473e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39477,0.041870344341494,0.00455485522029558,0.0329428281097146,0.0507978605732733,4.31415766893167e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39477,0.0408097720536203,0.00454763490959348,0.0318964076308171,0.0497231364764235,3.18363434110077e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39477,0.0401012493252904,0.00455709567668906,0.0311693417989798,0.0490331568516009,1.51275326395268e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39477,0.0430591958029395,0.00456246422725182,0.0341167659175259,0.0520016256883531,4.33645440970626e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39477,0.0298033123412848,0.0045640111217913,0.0208578505425738,0.0387487741399957,6.77684350773067e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39477,0.0481222816461491,0.00453472460631088,0.0392342214177798,0.0570103418745184,3.22071100905969e-26
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39477,0.0523840428502818,0.00459331878515303,0.0433811380313818,0.0613869476691817,5.22512281478496e-30
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23545.Total Lipids in Small LDL,39477,0.0468745701114935,0.00458418300395667,0.0378895714237384,0.0558595687992486,1.82463272645825e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23546.Phospholipids in Small LDL,39477,0.0472682555132293,0.00459203682445168,0.038267863337304,0.0562686476891546,9.04329982163684e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23547.Cholesterol in Small LDL,39477,0.0431509746196633,0.00458012630121611,0.0341739270692797,0.0521280221700469,5.06369823708906e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39477,0.0461468377917324,0.00458085734807022,0.0371683573895148,0.05512531819395,8.52417151938887e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39477,0.0314167679193274,0.00457785874512138,0.0224441647788895,0.0403893710597653,7.00812519359686e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23550.Triglycerides in Small LDL,39477,0.0503508209272591,0.00459349002075578,0.0413475804865777,0.0593540613679404,7.40587884721791e-28
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39477,-0.00753430456623252,0.00539154780410007,-0.0181017382622687,0.00303312912980362,0.162304493486401
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39477,-0.0150446546208967,0.00540755394286138,-0.025643460348905,-0.00444584889288836,0.00540639919297695
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39477,-0.0177101928065398,0.0053466270530571,-0.0281895818305317,-0.00723080378254788,0.000927076805926539
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39477,-0.0171914231837942,0.00548817195979721,-0.0279482402249968,-0.00643460614259169,0.0017367440370327
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39477,-0.0216595873281702,0.00555204254168093,-0.0325415907098649,-0.0107775839464756,9.61211104274349e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39477,-0.00305342614110743,0.0051694607506401,-0.013185569212362,0.00707871693014717,0.554752594363785
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39477,0.034958995569869,0.00438528114423648,0.0263638445271655,0.0435541466125724,1.67004792791898e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39477,-0.0410556780829312,0.00551004627321117,-0.0518553687784251,-0.0302559873874373,9.7437544856236e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23559.Total Lipids in Large HDL,39477,-0.0432201917263448,0.00542676537013212,-0.0538566518518038,-0.0325837316008859,1.77593524396572e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23560.Phospholipids in Large HDL,39477,-0.043822737345332,0.00531023950891871,-0.0542308067828126,-0.0334146679078513,1.67399403217643e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23561.Cholesterol in Large HDL,39477,-0.0458036316123298,0.00555549070383992,-0.0566923933918561,-0.0349148698328036,1.78559180214041e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39477,-0.0486187387478083,0.00556513924299759,-0.0595264116640836,-0.037711065831533,2.64967572533137e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39477,-0.0357724341010053,0.00548480130968374,-0.0465226446679854,-0.0250222235340252,7.14587775252157e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23564.Triglycerides in Large HDL,39477,0.0138789999121866,0.00443284494883363,0.00519062381247263,0.0225673760119005,0.00174565376020927
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39477,-0.0402822294389285,0.00484473276130716,-0.0497779056510906,-0.0307865532267665,9.95411079186129e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39477,-0.0372343017753092,0.00476675434472793,-0.0465771402909759,-0.0278914632596424,6.02086844988384e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39477,-0.0325098551960284,0.0046892854356579,-0.0417008546499179,-0.0233188557421389,4.28769681865869e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39477,-0.0490067740128961,0.00491283988375828,-0.0586359401850623,-0.0393776078407298,2.29791617580263e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39477,-0.0514854984346709,0.00490166653812941,-0.0610927648494045,-0.0418782320199372,1.01219808842672e-25
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39477,-0.0371347096139686,0.00493214875474774,-0.0468017211732741,-0.027467698054663,5.38726214148813e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39477,0.0275823900065381,0.0044701139304232,0.0188209667029086,0.0363438133101676,6.97981254571354e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39477,-0.00677340103450068,0.00442973255222945,-0.0154556768368704,0.00190887476786904,0.126265672795455
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23573.Total Lipids in Small HDL,39477,-0.00540020077047163,0.00445074579804659,-0.014123662534643,0.00332326099369969,0.225023971260166
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23574.Phospholipids in Small HDL,39477,-0.00833719354868724,0.00445702045552361,-0.0170729536415135,0.00039856654413903,0.0614226228640978
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23575.Cholesterol in Small HDL,39477,-0.0124265632074686,0.00442433058871991,-0.0210982511613596,-0.00375487525357758,0.00498056294541258
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39477,-0.0163241115850165,0.00440945030961388,-0.0249666341918597,-0.00768158897817332,0.000214579745022351
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39477,0.00130317926182231,0.00449596491609988,-0.00750891197373346,0.0101152704973781,0.771930787402757
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23578.Triglycerides in Small HDL,39477,0.0464093411106576,0.00480661437771702,0.0369883769303322,0.0558303052909829,5.37721793631993e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38727,0.00801423271556526,0.00449639936910603,-0.000798710047882548,0.0168271754790131,0.0747098460650601
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38727,0.00477392825814097,0.00449205243179272,-0.00403049450817275,0.0135783510244547,0.287912648426486
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38727,0.0118598669862015,0.00444832652477707,0.00314114699763848,0.0205785869747646,0.00768104301830942
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38727,-0.00994879444963978,0.00456978241104433,-0.0189055679752867,-0.000992020923992891,0.0294900701179478
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38727,-0.00770295942132356,0.0044050571390603,-0.0163368714138818,0.000930952571234641,0.0803699665812441
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39288,0.0363720463143914,0.00437722970744459,0.0277926760878,0.0449514165409828,1.04140394163702e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39288,-0.0118500759574474,0.00488435402298083,-0.0214234098424898,-0.00227674207240496,0.0152722045345796
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39288,-0.0150653239895461,0.00486373547457333,-0.0245982455197098,-0.00553240245938236,0.00195523809906224
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39288,0.00433843080743736,0.00469112613353765,-0.00485617641429644,0.0135330380291712,0.355075835890801
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39288,-0.0012211949126217,0.00474189094877919,-0.0105153011722289,0.00807291134698552,0.79677053258754
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39473,0.0531851492577728,0.00473270936665333,0.0439090388991323,0.0624612596164133,3.44281482471164e-29
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39473,0.0141032835808893,0.00457838985912682,0.00512963945700069,0.0230769277047778,0.00207080320128251
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39473,0.00634554576729892,0.00477257138550658,-0.00300869414829397,0.0156997856828918,0.183674023221192
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39473,0.0280843672099274,0.00446012219330051,0.0193425277110584,0.0368262067087964,3.12035429349204e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39473,-0.0317680460389627,0.00439358289968475,-0.0403794685223448,-0.0231566235555805,5.03326216535007e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39477,0.0157813483665605,0.00480989502796006,0.00635395411175876,0.0252087426213622,0.00103660190672793
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39477,-0.00791864585881238,0.00501761870431486,-0.0177531785192695,0.00191588680164475,0.114547246561351
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39477,-0.0128936409321157,0.00503312296775513,-0.0227585619489157,-0.00302871991531561,0.0104236989708431
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39477,0.00564859533817467,0.00492327660265385,-0.00400102680302688,0.0152982174793762,0.251265152424575
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39477,0.00249452030838899,0.00498654871964143,-0.00727911518210821,0.0122681557988862,0.61690620190851
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39477,-0.00672097505664859,0.00478254469851325,-0.0160947626657346,0.00265281255243739,0.159947941066547
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39477,0.00666340763586045,0.00463095664402801,-0.00241326738643444,0.0157400826581553,0.150203541496448
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39477,0.0160972909432773,0.00450282314547958,0.00727175757813728,0.0249228243084172,0.000351374581517935
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39477,-0.00832238579740187,0.00482089740241945,-0.017771344706144,0.00112657311134025,0.0843105991041353
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39477,-0.00272952510358232,0.00467865983876103,-0.0118996983875539,0.00644064818038931,0.559633208479918
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39477,0.031997949584994,0.00466815434441877,0.0228483670699332,0.0411475321000548,7.42321526794021e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39477,-0.0149173637722575,0.00492887350745858,-0.0245779558468763,-0.00525677169763867,0.00247784517417376
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39477,-0.0184670248078365,0.00498324371956822,-0.0282341824981902,-0.00869986711748279,0.000211432009158625
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39477,0.00940901656653752,0.00448676630051591,0.000614954617526347,0.0182030785155487,0.0360043343972311
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39477,0.00910933838859412,0.00488412683790743,-0.000463550213704441,0.0186822269908927,0.0621874649028543
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39477,0.0179163486945116,0.00450680339555927,0.00908301403921546,0.0267496833498078,7.05771340067358e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39477,-0.0219220493963044,0.00472071886649195,-0.0311746583746286,-0.0126694404179802,3.44854939664782e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39477,-0.0204360199362649,0.0046563564008333,-0.0295624784818982,-0.0113095613906317,1.14702651752171e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39477,-0.0129830511821528,0.00462122526777946,-0.0220406527070005,-0.00392544965730503,0.00496895801661847
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39477,0.020233059272503,0.00476924002796097,0.0108853488176995,0.0295807697273065,2.22409174834829e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39477,-0.0125521391934436,0.00450606008106498,-0.0213840169523309,-0.00372026143455622,0.00534910190290195
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39477,-0.0120403056639533,0.00472461216948868,-0.0213005455161511,-0.00278006581175549,0.010830634536112
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39477,0.0112905221367782,0.00444425686344677,0.00257977868442254,0.0200012655891339,0.0110798083852306
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39477,-0.0331558436695359,0.00499212915641287,-0.0429404168161051,-0.0233712705229666,3.20490500682641e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39477,0.0159887663386856,0.00462246901722223,0.00692872706493007,0.0250488056124412,0.000543785683399267
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39477,-0.0180784445167369,0.00445038632891735,-0.0268012017214149,-0.00935568731205889,4.88458802243255e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39477,-0.000664939146605592,0.00464477042880974,-0.00976868918707269,0.00843881089386151,0.886166718834539
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39477,0.0316464929074234,0.00460514996643281,0.0226203989732151,0.0406725868416317,6.57121597203334e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39477,-0.0388486241314671,0.00483115746155128,-0.0483176927561076,-0.0293795555068266,9.52474525147079e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39477,0.00978402330947497,0.00451939647048799,0.000926006227318506,0.0186420403916314,0.0304107481833407
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39477,-0.014342889048723,0.00455906677577738,-0.0232786599292467,-0.00540711816819936,0.00165822684565944
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39477,-0.0024519377426538,0.00449119026256405,-0.0112546706572793,0.00635079517197174,0.585112327093078
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39477,0.0206669725824226,0.00456336322631614,0.011722780658843,0.0296111645060023,5.97330230680654e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39477,-0.0272810307854304,0.00460348254751737,-0.0363038565785645,-0.0182582049922964,3.16602222953598e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39477,0.0207476090486703,0.00463366833451926,0.0116656191130125,0.0298295989843281,7.60296386784306e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39472,-0.0245973156028874,0.00507023439258062,-0.0345349750123454,-0.0146596561934294,1.23827522351547e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39472,0.000371266703452317,0.00466800941960898,-0.00877803175898128,0.00952056516588591,0.936608696885078
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39472,-0.0203052890807715,0.00443586558628176,-0.0289995856298837,-0.0116109925316592,4.74136949539715e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39472,0.0321144694266714,0.00534576262565169,0.0216367746803941,0.0425921641729487,1.9263445370847e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39472,0.0431543847673638,0.00495163260373907,0.0334491848640353,0.0528595846706924,3.19058052357885e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39477,0.000253076042975125,0.00499966296566437,-0.00954626336972703,0.0100524154556773,0.959630072079846
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39477,-0.0313868937806173,0.00508340244772649,-0.0413503625781613,-0.0214234249830734,6.80635859635481e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39477,-0.0348172618158005,0.00490433604527247,-0.0444297604645345,-0.0252047631670665,1.30809109217199e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39477,0.0142389282630287,0.00500616193217216,0.00442685087597122,0.0240510056500861,0.00445696996198979
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39477,0.0461813053382922,0.00480015693484084,0.0367729977460041,0.0555896129305802,7.510993787561e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39477,0.0468859366530381,0.0050130970478613,0.03706026643923,0.0567116068668463,9.6806055319098e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39477,-0.0555316823836783,0.00490351210466898,-0.0651425661088295,-0.0459207986585271,1.28921838578087e-29
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39477,-0.0525144777739288,0.00468804972155251,-0.0617030552281717,-0.0433259003196859,5.1557003808345e-29
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39477,-0.0269967384947032,0.0053073991938159,-0.0373992409145824,-0.0165942360748241,3.6871888387125e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39477,0.0557620894259826,0.00476696581881262,0.0464188364211098,0.0651053424308553,1.77379966342386e-31
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39477,-0.0192640776732479,0.00447029074851904,-0.0280258475403453,-0.0105023078061506,1.64731770305433e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39477,-0.0207559181109782,0.00445463638726044,-0.0294870054300086,-0.0120248307919477,3.19755424755332e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39477,-0.0246879319257192,0.004375725374372,-0.0332643536594883,-0.0161115101919501,1.70982664504396e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39477,0.0204294368113695,0.0048570019621786,0.0109097129654995,0.0299491606572396,2.6116909953879e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39477,0.058781959466955,0.00488250956409254,0.0492122407213337,0.0683516782125764,3.09915887286683e-33
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51023,0.000228149714658632,0.00381681404137177,-0.00725280580643004,0.0077091052357473,0.952335348731468
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51023,0.00380217502039706,0.00372679021873566,-0.00350233380832483,0.0111066838491189,0.307629517928796
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49112,-0.0027491259984742,0.00356899468905895,-0.00974435558902974,0.00424610359208134,0.441140895697499
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49112,0.00448243775909852,0.00385613498763618,-0.00307558681666839,0.0120404623348654,0.245077012491027
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49112,-0.00464921014179585,0.00383598529050128,-0.0121677413111783,0.00286932102758666,0.225524122896325
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49112,-0.00311081452572789,0.00353748112838012,-0.0100442775373529,0.00382264848589714,0.379199906334364
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24009.Traffic intensity on the nearest road,51023,-0.00698290259715262,0.0452222695484012,-0.095618550912019,0.0816527457177137,0.8772853160103
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24010.Inverse distance to the nearest road,51023,0.00199251848569712,0.00333533753411475,-0.00454474308116779,0.00852978005256202,0.550247766472027
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51023,-0.000529597940359685,0.00337093473830984,-0.00713663002744698,0.00607743414672761,0.8751615725168
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24012.Inverse distance to the nearest major road,51023,0.00405392082320093,0.00341059437541547,-0.00263084415261339,0.0107386857990152,0.234597301164309
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24013.Total traffic load on major roads,51023,0.0246680245078928,0.0310273020744496,-0.0361454875580284,0.085481536573814,0.426595714242128
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51023,0.00258567603103636,0.0301819966107912,-0.0565710373261144,0.0617423893881871,0.93172979376448
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51023,-0.00515240115022795,0.0038280426109984,-0.0126553646677848,0.00235056236732893,0.178325898757303
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51023,-0.00419362333097432,0.00382667921987524,-0.0116939146019298,0.00330666793998114,0.273136192640305
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51023,-0.00642904650934526,0.00378804428942337,-0.0138536133166151,0.000995520297924542,0.0896714216465288
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50976,-0.00880155307319004,0.00367439071265872,-0.0160033588700011,-0.00159974727637894,0.0166099977957977
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51023,0.000965107172854861,0.00334606910994525,-0.00559318828263783,0.00752340262834755,0.773019702035978
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24021.Average evening sound level of noise pollution,51023,0.000968246100691855,0.00334524186858575,-0.00558842796173622,0.00752492016311993,0.772247059166995
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51023,0.00095800275531642,0.0033460897182426,-0.00560033309243908,0.00751633860307192,0.774646589103694
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51023,0.000974461274648798,0.00334561391851197,-0.00558294200563466,0.00753186455493225,0.770850640502315
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51023,0.000967862020307478,0.00334568687987675,-0.00558968426425094,0.0075254083048659,0.772364356360853
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2405.Number of children fathered,35974,-0.0326319959554004,0.0330624750313337,-0.0974344470168144,0.0321704551060136,0.323672239465161
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",47930,0.009269973378952,0.0039568806418087,0.00151448732100695,0.0170254594368971,0.0191504183561401
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",47930,-0.00342053270633341,0.00361100603587514,-0.0104981045366487,0.00365703912398187,0.343519890680399
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24502.Water percentage, buffer 1000m",47930,-0.000376413756582994,0.00352900028151578,-0.00729325430835393,0.00654042679518794,0.915057225831563
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",47930,0.00719204867253246,0.00373451461648806,-0.000127599975784129,0.0145116973208491,0.0541370882962538
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",47930,-0.00258638282163029,0.00365120424284082,-0.0097427431375983,0.00456997749433773,0.478725901556957
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24505.Water percentage, buffer 300m",47930,0.00170392416649768,0.00354731189807299,-0.00524880715372537,0.00865665548672074,0.630988338545091
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51120,0.00738097774038912,0.00376890451846745,-6.07511580707869e-06,0.0147680305965853,0.0501946732586886
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51120,0.00558453655988769,0.00355673945560104,-0.00138667277309035,0.0125557458928657,0.116396919001513
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24508.Distance (Euclidean) to coast,51120,-0.00204941308711459,0.00340695197445731,-0.00872703895705093,0.00462821278282175,0.547486319229426
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28573,0.00719890506252982,0.052744968908528,-0.0961812339981852,0.110579044123245,0.891443591681217
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2704.Years since last cervical smear test,35350,-0.03937075853147,0.0323072684038979,-0.10269300460311,0.0239514875401699,0.223007890070081
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2714.Age when periods started (menarche),38639,-0.0266067740624469,0.0283503084323498,-0.0821733785898525,0.0289598304649586,0.348002680088585
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2734.Number of live births,39112,-0.009190651531112,0.0271666532965738,-0.0624372919923966,0.0440559889301726,0.73513699177188
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2744.Birth weight of first child,35307,-0.0182764323040068,0.0310087208673311,-0.0790535252039758,0.0425006605959622,0.555606947479862
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2754.Age at first live birth,33310,-0.0220433965861987,0.00562994223575793,-0.0330780833682842,-0.0110087098041131,9.08940412317299e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2764.Age at last live birth,33290,-0.0259435952953251,0.00563486502037865,-0.0369879307352672,-0.0148992598553829,4.19632141005676e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2794.Age started oral contraceptive pill,36868,-0.00481953350081135,0.00552495330881102,-0.0156484419860809,0.00600937498445824,0.383049314360558
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2804.Age when last used oral contraceptive pill,35715,-0.00263087986409389,0.00490984903319356,-0.0122541839691533,0.00699242424096549,0.592081106816091
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2867.Age started smoking in former smokers,29177,-0.0123509309950191,0.00716620914016744,-0.0263967009097473,0.00169483891970904,0.0848570482696924
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36197,-0.0108795351248224,0.0374235578757572,-0.0842297085613066,0.0624706383116618,0.77127529994003
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36194,-0.000635329978196746,0.0414454139348874,-0.0818683412905761,0.0805976813341826,0.98776969989632
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36213,0.00469280487225916,0.0422593198860039,-0.0781354621043085,0.0875210718488268,0.911580239633839
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36186,-0.0258087059761706,0.0413837206039062,-0.106920798359827,0.0553033864074856,0.532872998518209
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28739.Difficulty with standing for long periods,36226,0.0924006176014716,0.0389681320963169,0.0160230786926905,0.168778156510253,0.017746430580769
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36248,0.0962637552633091,0.0428065962598851,0.0123628265939343,0.180164683932684,0.0245423073587415
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28741.Difficulty learning a new task,36153,0.0284132267490318,0.0487110849489451,-0.0670604997509006,0.123886953248964,0.559701362494454
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28742.Difficulty with joining in community activities,35723,0.0868115497583425,0.0462949134798495,-0.00392648066216246,0.177549580178848,0.0607917616186477
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36162,0.038770746475782,0.040252036957221,-0.0401232459603712,0.117664738911935,0.335466295565121
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36246,0.0185732065562375,0.0543580006251904,-0.0879684746691357,0.125114887781611,0.732595239648977
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29028,0.118516315905358,0.0528486364035576,0.0149329885543851,0.222099643256331,0.0249673435481953
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2897.Age stopped smoking,29183,0.06366705056552,0.00859964038396117,0.0468117554129561,0.0805223457180839,1.53423904620822e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34910,0.00954537920599935,0.0103530729349151,-0.0107466437464343,0.029837402158433,0.356556465957329
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34910,-0.0166080258080028,0.0111266477694022,-0.0384162554360311,0.00520020382002554,0.135561260707855
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34910,0.0350885231219965,0.0376692853072392,-0.0387432760801923,0.108920322324185,0.351621046936157
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34910,0.0468938461565011,0.036728530676284,-0.0250940739690155,0.118881766282018,0.201710673873014
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34910,-0.0140022583885053,0.0397905011682935,-0.0919916406783606,0.06398712390135,0.724920327113903
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34910,-0.00351883859391963,0.0339382560380661,-0.0700378204285292,0.0630001432406899,0.917422369488209
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34910,-0.0140105069823771,0.0153883367903951,-0.0441716470915514,0.0161506331267973,0.362598392789716
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34910,-0.0263831834171276,0.0284759255371421,-0.0821959974699261,0.029429630635671,0.354202082968156
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34844,0.0485901391291275,0.0429924204593006,-0.0356750049711016,0.132855283229357,0.258415608918806
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29003.Recent feelings of depression,34841,-0.000410548939150097,0.0418843406599411,-0.0825038566326346,0.0816827587543344,0.992179464921841
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34851,0.030556414441079,0.034495596461858,-0.0370549546241627,0.0981677835063206,0.375741332158756
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29005.Recent feelings of tiredness or low energy,34856,0.0894167785569418,0.0350241957650655,0.0207693548574135,0.15806420225647,0.0106933297035588
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29006.Recent poor appetite or overeating,34858,0.050509453723269,0.0454569212929296,-0.0385861120108731,0.139605019457411,0.266528125317236
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29007.Recent feelings of inadequacy,34823,0.0734439439256806,0.0444457031370274,-0.0136696342228932,0.160557522074254,0.0984731330384238
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29008.Recent trouble concentrating on things,34855,0.074851368559255,0.0443611429149087,-0.0120964715539661,0.161799208672476,0.0915705326163781
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34846,0.107792520174257,0.0772667460066738,-0.0436503019988237,0.259235342347338,0.163022935418687
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29010.Recent thoughts of suicide or self-harm,34782,0.204246009539048,0.0833877890104454,0.040805943078575,0.367686075999521,0.0143269689466762
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#0.Substances taken for depression_None of options listed,32526,-0.0123102329698918,0.0205991690572115,-0.0526846043220264,0.0280641383822428,0.550116986142174
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32526,-0.0365257745214605,0.0363586324734576,-0.107788694169437,0.0347371451265163,0.315118972783073
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32526,0.00509261316714286,0.0201387210426189,-0.0343792800763902,0.0445645064106759,0.800369498847945
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32526,-0.0616477151611456,0.0581291304864816,-0.17558081091465,0.0522853805923583,0.28893288289657
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32526,-0.025314920365643,0.0344837131879859,-0.0929029982140953,0.0422731574828094,0.462900117080278
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32526,-0.0249948701146999,0.0373049146552408,-0.0981125028389718,0.048122762609572,0.502865777819836
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32526,0.00654876167584097,0.0420152653670311,-0.07580115844354,0.088898681795222,0.876142082502919
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32526,-0.00896496384109582,0.0530499545980658,-0.112942874853305,0.0950129471711131,0.865807679995707
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32526,-0.0351259889141888,0.0414762964082604,-0.116419529874379,0.0461675520460015,0.397078099566188
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32526,-0.0111572791196209,0.0209263258068806,-0.0521728777011069,0.0298583194618651,0.593929909982376
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32526,0.0753781898244027,0.0301188075021256,0.0163453271202365,0.134411052528569,0.0123434355897603
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32526,0.0101235555615978,0.0480430326382225,-0.0840407884093183,0.104287899532514,0.833111895557347
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32526,-0.0467355092229872,0.0598002440927401,-0.163943987644758,0.0704729691987835,0.434513915304958
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32526,0.00169821699237771,0.0364434421807159,-0.0697309296818255,0.0731273636665809,0.962834142701078
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32526,-0.0350277184641958,0.061270576112521,-0.155118047644737,0.0850626107163453,0.567547470030942
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32526,-0.0569027128068687,0.0601702621793168,-0.17483642667833,0.0610310010645923,0.344330567975592
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32526,0.0246161419311784,0.0318199764473767,-0.0377510119056799,0.0869832957680367,0.439184604303025
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32526,-0.0173927613713842,0.0311666960037158,-0.0784794855386673,0.0436939627958988,0.576820568378734
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32526,0.0168300426609243,0.0440677973496267,-0.069542840144344,0.103202925466193,0.702535632397774
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29058.Recent feelings or nervousness or anxiety,34683,0.00440561851739455,0.0403299435533293,-0.074641070847131,0.0834523078819201,0.91301464243644
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29059.Recent inability to stop or control worrying,34690,0.0155940424163987,0.0420657327048037,-0.0668547936850166,0.0980428785178139,0.710863366915163
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29060.Recent worrying too much about different things,34683,0.0204704097714733,0.0385962378832986,-0.055178216479792,0.0961190360227387,0.595864094338421
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29061.Recent trouble relaxing,34689,-0.0137005306507143,0.040562044628729,-0.0932021381230232,0.0658010768215945,0.735545132815681
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29062.Recent restlessness,34691,-0.0201801794320693,0.056617495910731,-0.131150471417102,0.0907901125529635,0.721525439027052
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29063.Recent easy annoyance or irritability,34676,0.0404184392956837,0.0408162451640539,-0.0395814012258618,0.120418279817229,0.322072269003633
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29064.Recent feelings of foreboding,34663,0.0745423045319347,0.046252951158547,-0.0161134797388175,0.165198088802687,0.107073293068507
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32526,0.0196836307141356,0.0207460658229275,-0.0209786582988023,0.0603459197270735,0.342754598987221
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32526,0.0564918515510426,0.0338960833371289,-0.00994447178972997,0.122928174891815,0.0956263552017519
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32526,0.0652041829424669,0.0448618631790513,-0.0227250688884736,0.153133434773407,0.146136869675817
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32526,-0.00977681215345303,0.0497730386355524,-0.107331967879136,0.0877783435722297,0.8442798870124
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32526,0.019413210351247,0.0312158405409118,-0.04176983710894,0.0805962578114341,0.534022318769116
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32526,-0.00369385091113205,0.0337377765051979,-0.0698198928613198,0.0624321910390557,0.912818697413716
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32526,-0.00440241620014276,0.0337524342141043,-0.0705571872597872,0.0617523548595017,0.896227239590331
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32526,-0.000848979669460186,0.0305474331949013,-0.0607219487314668,0.0590239893925464,0.97782854537329
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32526,0.00476645755892212,0.0405901770421896,-0.0747902894437695,0.0843232045616137,0.906522949500208
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29076.Felt loved as a child,34640,-0.0595545853014713,0.0356375974806136,-0.129404276363474,0.0102951057605312,0.0947276583517473
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29077.Physically abused by family as a child,34647,0.0862084288762239,0.0454560055070239,-0.00288534191754297,0.175302199669991,0.0579174198615967
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29078.Felt hated by family member as a child,34632,0.10229243452845,0.0463037509338902,0.011537082698025,0.193047786358874,0.0271844247569333
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29079.Sexually molested as a child,34551,0.0735130806338944,0.0629862658894455,-0.0499400005094188,0.196966161777208,0.243184424501131
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29080.Someone to take to doctor when needed as a child,34627,-0.0290823528517186,0.0530198149000855,-0.133001190055886,0.074836484352449,0.583347260544262
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34631,0.0745276565785209,0.0621153339360253,-0.0472183979360886,0.19627371109313,0.230232917330466
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34572,0.0309829140741319,0.0495610080474284,-0.0661566616988278,0.128122489847092,0.531887919763651
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34640,0.0225884832281842,0.054536614517137,-0.0843032812254043,0.129480247681773,0.678743704927006
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34603,0.185600397009173,0.0745873894059839,0.0394091137734441,0.331791680244901,0.0128483513718637
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34602,0.20227878817868,0.0725862107319372,0.0600098151440831,0.344547761213277,0.00533348696358145
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29086.Experienced a violent or sexual assault,34640,-0.0161295979504578,0.0612994942459904,-0.136276606672599,0.104017410771683,0.792457145768247
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29087.Experienced a life-threatening injury or illness,34645,0.0734982981844399,0.0431733512765059,-0.0111214703175117,0.158118066686392,0.0887092951368066
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29088.Experienced a marital separation or divorce,34645,0.0321377393956462,0.038705650901892,-0.0437253363720621,0.108000815163355,0.406381180466023
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29089.Experienced the death of a spouse or partner,34659,-0.0276118136503889,0.0619013267631606,-0.148938414106184,0.0937147868054059,0.655561591283519
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34645,0.00428867683577011,0.0478198170718646,-0.0894381646250845,0.0980155182966247,0.928539923863625
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29091.Frequency of drinking alcohol,34650,-0.0831243311402221,0.0330816486899936,-0.147964362572609,-0.0182842997078347,0.0119955091503831
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33569,-0.0453876376471303,0.0367749387711042,-0.117466517638494,0.0266912423442338,0.217158185833936
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33583,-0.0731057881924849,0.036885457875559,-0.145401285628581,-0.000810290756389234,0.0475109698730924
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29104.Ever used cannabis,34639,-0.0355542996106621,0.0428069943417496,-0.119456008520491,0.0483474092991671,0.406233743958526
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29108.Ever thought that life not worth living,34589,0.0598759816249836,0.0392789025184369,-0.0171106673111526,0.13686263056112,0.127443237910763
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29109.Ever contemplated self-harm,34607,-0.0275694262693004,0.0510722672477827,-0.127671070074955,0.0725322175363537,0.589337828190737
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29111.Ever self-harmed,34625,0.0395977462232082,0.0779177940218479,-0.113121130059614,0.19231662250603,0.611324195300659
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34633,-0.0602655927401162,0.0561484255663216,-0.170316506850107,0.0497853213698741,0.283148695389387
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33175,-0.0566930918299672,0.0424232846901268,-0.139842729822616,0.0264565461626814,0.181461879980794
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33175,-0.0436483575703086,0.0333188845348787,-0.108953371258671,0.0216566561180536,0.190221856767811
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33175,-0.0474033439752604,0.0347301139082006,-0.115474367235334,0.0206676792848128,0.172315533977692
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33175,-0.03685597816091,0.0463245673651974,-0.127652130196697,0.0539401738748768,0.42628292713052
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34626,-0.0583740802890186,0.0366058128340301,-0.130121473443718,0.0133733128656803,0.110816086294004
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X29153.Pain or discomfort today,34641,0.00620564493774507,0.0350327846161244,-0.0624586129098587,0.0748699027853488,0.859403153745072
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29154.Anxiety or depression today,34641,0.0122891382223869,0.0427451018948064,-0.0714912614914336,0.0960695379362075,0.773736436504691
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29166.Frequency of confiding in someone close,34400,-0.0832085950445838,0.0340976054676035,-0.150039901761087,-0.0163772883280811,0.0146911856685845
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34607,0.0201980940233071,0.0107621135164824,-0.000895648468998429,0.0412918365156126,0.0605756478631453
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34607,-0.0363054948083099,0.0106932507803488,-0.0572642663377935,-0.0153467232788263,0.000688320127142828
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34607,-0.0270739743511446,0.0132646589716651,-0.0530727059356082,-0.00107524276668109,0.0412691705142286
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34607,0.025547134205867,0.0158655099892231,-0.00554926537301025,0.0566435337847443,0.107376829809907
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34607,-0.0164954943288593,0.0245631867687173,-0.0646393403955451,0.0316483517378265,0.501882416561468
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34607,-8.15248684271426e-05,0.011582459475393,-0.0227831454401974,0.0226200957033431,0.994384147537443
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34605,0.0254682461099641,0.0126975327609095,0.000581081898581463,0.0503554103213467,0.0449065235659651
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34605,-0.0499285570341975,0.0180218456688101,-0.0852513745450653,-0.0146057395233297,0.00560756782873035
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34605,-0.00841740431604616,0.0288960005234586,-0.0650535653420249,0.0482187567099326,0.770827527113018
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34605,-0.00690153638209916,0.0283631301050545,-0.0624932713880059,0.0486901986238076,0.807756160686978
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34605,-0.0488520138036264,0.0382756118662573,-0.123872213061491,0.0261681854542379,0.201869225086289
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34605,0.0111353525634809,0.019015131875257,-0.0261343059120227,0.0484050110389846,0.558153418408134
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34423,-0.0794673261853834,0.041505633398018,-0.160818367645499,0.0018837152747319,0.0555685518792536
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29172.Freuency of feeling that lacks companionship,34558,0.117758599591531,0.0377980227872432,0.043674474928534,0.191842724254527,0.00184137906418368
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29173.Frequency of feeling left out,34513,0.0546618961987216,0.0391143391847278,-0.022002208603345,0.131326001000788,0.162295389308501
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29174.Frequency of feeling isolated from others,34544,0.093880066181739,0.0401307533551083,0.0152237896057268,0.172536342757751,0.0193354104263711
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29175.Tendency to bounce back quickly after hard times,34624,-0.00531718964013003,0.0341031260730276,-0.0721593167432641,0.061524937463004,0.876102929123908
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29176.Ability to make it through stressful events,34624,0.00870576010432377,0.0333486354548213,-0.056657565387126,0.0740690855957736,0.794056659684134
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29177.Quick recovery from stressful events,34624,0.00164856810689825,0.0336285608551024,-0.0642634111691024,0.0675605473828989,0.960901990921016
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29178.Hard to snap back when something bad happens,34624,0.0323301218228485,0.0333432679934413,-0.0330226834442965,0.0976829270899934,0.332260389546358
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29179.Comes through difficult times with little trouble,34624,-0.00904661938770064,0.0335624090389594,-0.0748289411040611,0.0567357023286598,0.787514572897739
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29180.Tendency to take a long time to get over setbacks,34624,-0.00281401094308105,0.0336301042663592,-0.068729015305145,0.0631009934189829,0.933316107996394
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29181.General happiness,34557,0.10475570455523,0.0351974834109243,0.0357686370698185,0.173742772040642,0.00292471809711893
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29182.Belief that own life is meaningful,34458,-0.0860758180306539,0.0350447533519156,-0.154763534600409,-0.0173881014608993,0.0140586624263339
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28726,0.0766247122687719,0.0508466833947832,-0.0230347871850032,0.176284211722547,0.13188183358886
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2946.Father's age,33853,-0.0232961165459441,0.00805520980125009,-0.0390843277563943,-0.00750790533549394,0.00383555709283363
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2966.Age high blood pressure diagnosed,28943,-0.00602061938245331,0.0132750304740446,-0.0320396791115807,0.019998440346674,0.65018678822625
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50563,0.0209769386466234,0.00351063935009508,0.014096085520437,0.0278577917728097,2.32650664971796e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50563,0.0244356914589675,0.00413817915673251,0.0163248603117717,0.0325465226061632,3.5704446704659e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30020.Haemoglobin concentration,50563,0.0245418013487894,0.00441586772916307,0.0158867005996298,0.033196902097949,2.76056171483212e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30030.Haematocrit percentage,50563,0.024740216304925,0.00432368265728256,0.0162657982966512,0.0332146343131989,1.06387649948247e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30040.Mean corpuscular volume,50563,-0.00415248514321762,0.00350832084031609,-0.0110287939902372,0.00272382370380192,0.236577845696285
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50562,-0.00434095528145618,0.00351856035778249,-0.0112373335827099,0.0025554230197975,0.217314198349301
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50562,-0.00195926925155449,0.00343185805816921,-0.00868571104556615,0.00476717254245716,0.568067991232961
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50563,0.0244315211443202,0.00334830574406805,0.0178688418859468,0.0309942004026936,3.03172624973779e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30080.Platelet count,50563,-0.00128233042207748,0.00354451171634361,-0.00822957338611096,0.005664912541956,0.717519939651147
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30090.Platelet crit,50563,0.000225552472994316,0.00363536615822527,-0.00689976519712722,0.00735087014311585,0.950528297405139
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50563,0.00226494634183062,0.00341487178948074,-0.00442820236555162,0.00895809504921287,0.507170060765296
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30110.Platelet distribution width,50563,0.00415570354531268,0.00337978712721861,-0.0024686792240358,0.0107800863146612,0.218866931844247
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30120.Lymphocyte count,50529,0.0108866457166347,0.00357797407584875,0.00387381652797116,0.0178994749052983,0.00234706166332002
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30130.Monocyte count,50529,0.000976608850915412,0.00355869646529537,-0.00599843622106352,0.00795165392289434,0.783757227769854
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30140.Neutrophill count,50529,0.0199521810654593,0.00347893480050967,0.0131334688564603,0.0267708932744582,9.84836066597467e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30150.Eosinophill count,50529,0.00665264580660052,0.00341344697376098,-3.77102619710055e-05,0.013343001875172,0.0513115751437585
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30160.Basophill count,50529,0.0840620282986438,0.0228312905197113,0.0393126988800096,0.128811357717278,0.000231978784494465
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30170.Nucleated red blood cell count,50529,-0.0383825407217304,0.105662351412812,-0.245480749490842,0.168715668047381,0.716416130562328
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30180.Lymphocyte percentage,50529,-0.0082563691947253,0.00351281453918483,-0.0151414856915276,-0.00137125269792304,0.0187626435022683
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30190.Monocyte percentage,50529,-0.0125629765522195,0.00351836204614946,-0.0194589661626725,-0.00566698694176661,0.000356669488879651
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30200.Neutrophill percentage,50529,0.00930272435480008,0.00346095539432758,0.00251925178191803,0.0160861969276821,0.00719461650393385
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30210.Eosinophill percentage,50529,0.000713031519511238,0.00336871123993883,-0.00588964251076887,0.00731570554979134,0.832371574953259
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30220.Basophill percentage,50529,0.0119185145658805,0.00334580090028822,0.00536074480131559,0.0184762843304454,0.000368357904589769
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50528,-0.0411621936927594,0.105954571338543,-0.248833153516304,0.166508766130786,0.697657236773027
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30240.Reticulocyte percentage,50092,0.00905738477143769,0.00360141422258864,0.00199861289516396,0.0161161566477114,0.0119107798237285
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30250.Reticulocyte count,50092,0.0132415318535422,0.00369154921334887,0.00600609539537845,0.020476968311706,0.000335131742934775
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30260.Mean reticulocyte volume,50092,0.0074692191235602,0.00347921189864117,0.000649963802223499,0.0142884744448969,0.0318172708288704
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30270.Mean sphered cell volume,50092,0.00425162466293549,0.00349621254542059,-0.00260095192608887,0.0111042012519599,0.223970782921403
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30280.Immature reticulocyte fraction,50092,0.00815207280085223,0.00363154218600495,0.00103425011628253,0.0152698954854219,0.0247895047475123
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50092,0.00954681929914338,0.00368238904456535,0.00232933677179529,0.0167643018264915,0.00953170485563623
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30300.High light scatter reticulocyte count,50092,0.0127128261917728,0.00374481356743963,0.00537299159959112,0.0200526607839545,0.000687849270561404
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30500.Microalbumin in urine,31818,0.00886770562271763,0.00631220771179863,-0.00350422149240769,0.021239632737843,0.160104889515591
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50677,-0.0175753013453016,0.00357461627012684,-0.0245815492347502,-0.010569053455853,8.85368743026435e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30520.Potassium in urine,50614,-0.0180185586581847,0.00331272901582031,-0.0245115075291925,-0.0115256097871769,5.39923630442337e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30530.Sodium in urine,50619,0.00450827239705301,0.00344809638606274,-0.00224999651962995,0.011266541313736,0.191065373212303
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30600.Albumin,47948,-0.0271328081860196,0.00373517489850169,-0.0344537509870829,-0.0198118653849563,3.86848886356367e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30610.Alkaline phosphatase,50160,0.0406388195841367,0.00351339755585788,0.0337525603746553,0.0475250787936182,7.20927371776283e-31
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30620.Alanine aminotransferase,50152,0.0101412368821744,0.00371891120940261,0.00285217091174529,0.0174303028526035,0.0063967610441155
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30630.Apolipoprotein A,47821,-0.038533078323143,0.00406819045922104,-0.0465067316232162,-0.0305594250230698,2.99658771963458e-21
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30640.Apolipoprotein B,49999,0.0466053720251218,0.0035563742287618,0.0396348785367487,0.053575865513495,4.10938161623254e-39
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30650.Aspartate aminotransferase,50074,0.0224197966813968,0.00348989604390989,0.0155796004353334,0.0292599929274602,1.3483673062585e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30660.Direct bilirubin,46076,-0.027905191604428,0.00379699864073761,-0.0353473089402737,-0.0204630742685823,2.061710381083e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30670.Urea,50152,-0.00527373351049649,0.00365755944224912,-0.0124425500173048,0.00189508299631179,0.149350323021787
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30680.Calcium,47946,-0.00434527687800891,0.00363526367807475,-0.0114703936870354,0.00277983993101761,0.231976644417234
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30690.Cholesterol,50165,0.0402725181175945,0.00366671099445852,0.0330857645684558,0.0474592716667332,5.29106194021029e-28
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30700.Creatinine,50155,0.00514193968472979,0.00443453018283289,-0.00354973947362267,0.0138336188430823,0.246253600899573
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30710.C-reactive protein,50083,0.0329473749158749,0.00381961625443956,0.0254609270571734,0.0404338227745765,6.71635970653771e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30720.Cystatin C,50160,0.0432426487447616,0.00408739801687338,0.0352313486316898,0.0512539488578334,4.18561319711315e-26
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50150,0.0126310295478723,0.00379254593890206,0.00519763950762424,0.0200644195881203,0.000868131368801061
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30740.Glucose,47911,-0.018533763524979,0.00369869478965152,-0.025783205312696,-0.011284321737262,5.45620565430412e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),49935,0.0266553597909714,0.00370172755112186,0.0193999737907725,0.0339107457911702,6.1486689478306e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30760.HDL cholesterol,47929,-0.0419336734799812,0.00430758589387906,-0.0503765418319841,-0.0334908051279782,2.35487663200869e-22
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30770.IGF-1,50042,0.003369613766736,0.00361982601978775,-0.003725245232048,0.01046447276552,0.35192563594519
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30780.LDL direct,50109,0.0476925041724296,0.00362259065045,0.0405922264975476,0.0547927818473116,1.85391577303535e-39
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30790.Lipoprotein A,44946,-0.00022907107386948,0.0038439929707989,-0.00776329729663532,0.00730515514889636,0.952481187016489
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30810.Phosphate,47884,-0.00681403866511157,0.00363610861777019,-0.0139408115559411,0.000312734225717996,0.0609436475697672
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30830.SHBG,47705,0.000789254910354833,0.00422860573325314,-0.00749881232682131,0.00907732214753098,0.851939309946849
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30840.Total bilirubin,50061,-0.0251303743177778,0.00355992526056633,-0.0321078278284878,-0.0181529208070678,1.7158375264715e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30850.Testosterone,48045,0.020406593342315,0.00602136373267339,0.00860472042627515,0.0322084662583548,0.000702518065526209
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30860.Total protein,47929,-0.0181749901611693,0.00368988837195123,-0.0254071713701937,-0.0109428089521449,8.46503736066854e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30870.Triglycerides,50144,0.0427528625233519,0.00364811687795902,0.0356025534425522,0.0499031716041516,1.21896375035933e-31
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30880.Urate,50131,-0.00411873543987217,0.00441269698050595,-0.0127676215216638,0.00453015064191948,0.350630938818347
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30890.Vitamin D,49098,-0.0232042695663003,0.00380058555998325,-0.0306534172638675,-0.0157551218687332,1.04009332080017e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3137.Number of measurements made,49228,-0.0254957627141823,0.0259688370308322,-0.0763946832946133,0.0254031578662488,0.326216128598956
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3143.Ankle spacing width,39505,0.00709675149674608,0.00628710723344077,-0.00522597868079783,0.01941948167429,0.259008590905765
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39504,-0.00819256255117183,0.00483588048938092,-0.0176708883103584,0.00128576320801477,0.0902623605390455
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3146.Speed of sound through heel,39505,-0.0122304741865682,0.00469711666518447,-0.0214368228503297,-0.0030241255228066,0.0092276648451808
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39505,-0.0110900572567631,0.00474415488221642,-0.0203886008259073,-0.00179151368761891,0.0194192247059438
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3148.Heel bone mineral density (BMD),39496,-0.0112983321046659,0.00474841975543045,-0.0206052348253096,-0.00199142938402221,0.0173533458647178
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X3526.Mother's age at death,35018,-0.00785330403511366,0.0062816740452269,-0.0201653851637584,0.00445877709353106,0.211255323262993
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X3581.Age at menopause (last menstrual period),30227,0.00408338475701705,0.00853992969004715,-0.0126548774354754,0.0208216469495095,0.632558412563851
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30183,0.00750045278418503,0.00765319798319696,-0.00749981526288101,0.0225007208312511,0.327103055212677
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4100.Ankle spacing width (left),32563,0.00985164435840564,0.0080902822512307,-0.00600530885400654,0.0257085975708178,0.223365952221861
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32562,-0.00235479744551972,0.00623567991529961,-0.014576730079507,0.00986713518846751,0.705712583526386
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4103.Speed of sound through heel (left),32563,-0.00643407392579332,0.00608652245439179,-0.0183636579364012,0.0054955100848146,0.290494464681698
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32563,-0.00502898372056279,0.00614012875696904,-0.0170636360842221,0.00700566864309653,0.412788559123208
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32556,-0.00585100823079133,0.00615084650449157,-0.0179066673795948,0.00620465091801215,0.341502641192505
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32563,-0.00504434929360132,0.0061401916301004,-0.0170791248885981,0.00699042630139547,0.41136716382597
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4119.Ankle spacing width (right),32554,0.0146738642001438,0.00795205433311702,-0.000912162292765533,0.0302598906930532,0.0650290223514564
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32554,0.00309558378296008,0.00629071678186335,-0.00923422110949209,0.0154253886754122,0.622669835838354
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4122.Speed of sound through heel (right),32554,-0.00373848057096818,0.00612391829992257,-0.0157413604388164,0.00826439929688006,0.541565152054819
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32554,-0.00151142301860522,0.00618494553561069,-0.0136339162684022,0.0106110702311917,0.806949054370214
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32544,-0.00154379132503357,0.00621366754299908,-0.0137225797093118,0.0106349970592446,0.803791426314032
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32554,-0.00151518668562341,0.00618496490040704,-0.0136377178904212,0.0106073445191744,0.806478452172999
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4194.Pulse rate,32854,0.0054747976807171,0.00588708515338927,-0.00606388921992586,0.0170134845813601,0.352412886972809
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4195.Pulse wave reflection index,32854,0.00264033160264033,0.00575780436219139,-0.00864496494725481,0.0139256281525355,0.646557150846436
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4196.Pulse wave peak to peak time,32849,-0.0129897606152689,0.00620176143309421,-0.0251452130241336,-0.00083430820640428,0.036240931075151
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4198.Position of the pulse wave peak,32854,0.0184997585695529,0.00591475489410499,0.0069068389771071,0.0300926781619987,0.00176724025503715
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4199.Position of pulse wave notch,32854,0.00536901562514139,0.00582241513765594,-0.00604291804466426,0.016780949294947,0.356486225878969
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32854,0.0162986478927509,0.00606604812980886,0.0044091935583255,0.0281881022271762,0.00722588580903858
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4269.Number of triplets attempted (left),32722,0.0783314337763036,0.123673162812643,-0.164067965336476,0.320730832889083,0.526505451426478
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4270.Volume level set by participant (left),32638,-0.039231466443707,0.0362052297685427,-0.110193716790051,0.0317307839026367,0.278578340396192
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4276.Number of triplets attempted (right),32733,0.171621307023173,0.12306604244831,-0.069588136175514,0.412830750221861,0.163187630428949
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4277.Volume level set by participant (right),32635,-0.00402098715847648,0.0361194505223569,-0.074815110182296,0.066773135865343,0.911361412729739
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4288.Time to answer,32890,-0.0105414877892503,0.00663047571239564,-0.0235372201855457,0.00245424460704519,0.11190274418763
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4290.Duration screen displayed,32890,-0.00932536396979864,0.00592937369746195,-0.0209469364168241,0.00229620847722679,0.115814037616053
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X46.Hand grip strength (left),51359,-0.00322472449230644,0.0047687358451366,-0.0125714467487742,0.00612199776416131,0.498905340338617
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X47.Hand grip strength (right),51339,-0.00674754637072127,0.00472315516787101,-0.0160049304997484,0.00250983775830591,0.153127744816415
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X48.Waist circumference,51416,0.0133841035063977,0.00748260466395433,-0.0012818016349528,0.0280500086477482,0.0736748014214681
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X4803.Tinnitus,32682,0.0578642572419108,0.0441071453124566,-0.0285857475705042,0.144314262054326,0.189587311448232
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4825.Noisy workplace,32813,0.0293524748529848,0.0484675981803071,-0.0656440175804171,0.124348967286387,0.544788940863283
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4836.Loud music exposure frequency,32755,0.108053842766396,0.0516862417512299,0.00674880893398504,0.209358876598806,0.0365947114548785
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X49.Hip circumference,51412,-0.0116893601876724,0.00590391216544931,-0.0232610280319531,-0.000117692343391776,0.0477208075772088
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X50.Standing height,51388,-0.012229594520514,0.00468690675246167,-0.0214159317553389,-0.00304325728568916,0.00907739752117389
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X5057.Number of older siblings,32032,0.0578371209786133,0.0380978568542347,-0.0168346784556868,0.132508920412913,0.129022821259261
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X51.Seated height,51250,-0.00381509086121382,0.00434498085483399,-0.0123312533366884,0.00470107161426079,0.379926732372472
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5181.Ever had eye surgery,29964,0.0860397445996563,0.095405068904136,-0.10095419045245,0.273033679651763,0.367179482387004
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29949,-0.00542079156724197,0.00725357691628275,-0.0196378023231562,0.00879621918867223,0.454895248026174
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29947,-0.0176740457578531,0.00717656974816635,-0.0317401224642592,-0.00360796905144707,0.0138153654585604
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5190.Duration at which refractometer first shown (right),29892,-0.0111001381218152,0.00710070634960821,-0.0250175225670473,0.00281724632341685,0.118047622222977
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5193.Duration at which refractometer first shown (left),29890,-0.00900432782365837,0.00713016472562168,-0.0229794506858769,0.00497079503856013,0.206691957801977
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5199.logMAR, initial (right)",29926,-0.0321814172873444,0.045038324766185,-0.120456533829067,0.0560936992543782,0.474924499256731
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5200.Final number of letters displayed (right),29926,-0.0539492700634468,0.349314250308028,-0.738605200667182,0.630706660540288,0.877265299129318
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5201.logMAR, final (right)",29874,-0.00275463534203297,0.00688151225633245,-0.0162423993644446,0.0107331286803786,0.6889534261067
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5202.Number of rounds to result (right),29926,-0.0119826735509284,0.0430264201270936,-0.0963144570000319,0.0723491098981751,0.780641365329459
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5206.logMAR, initial (left)",29922,-0.0144591204484207,0.0447121639698762,-0.102094961829378,0.0731767209325366,0.746416922561978
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5207.Final number of letters displayed (left),29922,0.118273555252949,0.305373173385421,-0.480257864582475,0.716804975088374,0.69854160572111
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5208.logMAR, final (left)",29872,-0.00839963186594353,0.0068896240322708,-0.0219032949691943,0.00510403123730723,0.222827014889867
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5209.Number of rounds to result (left),29918,0.080321853484505,0.043012495113895,-0.00398263693872923,0.164626343907739,0.0618930541246932
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29685,0.0140489544678274,0.00717676964201302,-1.7514030518152e-05,0.0281154229661729,0.0503293897674726
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29685,0.0117890020886631,0.00705661636378344,-0.00204196598435243,0.0256199701616787,0.0948483067064342
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5256.Corneal hysteresis (right),29685,-0.00622752471772856,0.00721584074658053,-0.0203705725810264,0.00791552314556928,0.38815363324544
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5257.Corneal resistance factor (right),29685,0.00206427856375347,0.00710159067270316,-0.0118548391547447,0.0159833962822517,0.771307689673657
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29665,0.00494992694737781,0.00724317498693326,-0.00924669602701138,0.019146549921767,0.49438652629093
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29665,0.00302632190063314,0.00707777860630597,-0.0108461241677266,0.0168987679689928,0.668972241865658
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5264.Corneal hysteresis (left),29665,-0.00154024068312538,0.00719444991746302,-0.0156413625213529,0.0125608811551021,0.830486463234634
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5265.Corneal resistance factor (left),29665,0.0013385307661875,0.0070585674439387,-0.0124962614239323,0.0151733229563073,0.849604083785831
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29759,-0.0898948565777116,0.187886122865313,-0.458151657393725,0.278361944238302,0.63234488121719
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51317,0.0153083355036537,0.0203868112633947,-0.0246498145725998,0.0552664855799073,0.452722849905687
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51317,-0.0212319612845829,0.0227434282024401,-0.0658090805613656,0.0233451579921997,0.35054804569318
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51317,-0.0501522763038308,0.0535888257820427,-0.155186374836634,0.0548818222289729,0.349347376586675
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51317,-0.0357805196128743,0.00938501416426134,-0.0541751473748265,-0.0173858918509221,0.000137859606186854
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51317,0.0197213827711712,0.00841669452950839,0.00322466149333471,0.0362181040490076,0.0191299789878858
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37510,0.00250493417941944,0.00972098158225003,-0.0165481897217906,0.0215580580806295,0.796655254546141
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37510,0.0332781650037763,0.0344938706687919,-0.0343298215070558,0.100886151514608,0.334684183827291
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37510,-0.0344052278448564,0.0165373587150922,-0.0668184509264371,-0.00199200476327575,0.0375024398325107
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37510,0.0136458160687695,0.0104904112106714,-0.00691538990414641,0.0342070220416854,0.193352497973323
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51398,0.0221566488205064,0.0191210454731753,-0.0153206003069173,0.0596338979479301,0.246565222376993
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51398,0.0221566488205064,0.0191210454731753,-0.0153206003069173,0.0596338979479301,0.246565222376993
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51398,-0.0281559166680216,0.0139847526765269,-0.0555660319140143,-0.000745801422028892,0.044089676050031
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51398,-0.00914574510733575,0.021721753866272,-0.0517203826852289,0.0334288924705574,0.673728558896802
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51398,0.0609890420605535,0.0536084139905277,-0.0440834493608808,0.166061533481988,0.255265415799065
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51398,0.00319976309539227,0.0376953031329987,-0.0706830310452851,0.0770825572360697,0.932353491249609
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51398,0.0773157224510521,0.0563703559147404,-0.0331701751418391,0.187801620043943,0.170209433673034
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51316,-0.0178007637090627,0.0107327615417359,-0.038836976330865,0.00323544891273956,0.097219015644794
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51316,0.0212476999845741,0.0184934709095476,-0.0149995029981392,0.0574949029672875,0.250594934022039
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51316,-0.0220674124298015,0.00899649246620442,-0.0397005376635622,-0.00443428719604085,0.0141775145393568
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51316,0.0437356288618586,0.0168777193437336,0.0106552989481407,0.0768159587755764,0.00956581853887542
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51316,0.0188271615524139,0.0146952139846842,-0.0099754578575671,0.0476297809623949,0.200142529383407
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51316,0.0595466241210953,0.011944704713014,0.0361350028835879,0.0829582453586028,6.22775366346368e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29952,0.186759956566896,0.0315729141889047,0.124877044756642,0.248642868377149,3.49482138609645e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29952,0.0858704330411582,0.0275719871483467,0.0318293382303987,0.139911527851918,0.0018516952131829
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29952,0.0467279450739334,0.0347384050031047,-0.0213593287321518,0.114815218880019,0.178630776566062
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29952,-0.0690080827772199,0.028584714536558,-0.125034123268873,-0.0129820422855663,0.015800815067046
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51270,0.0337576272138263,0.0299357129771426,-0.0249163702213732,0.0924316246490257,0.259468875640838
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51270,0.0377136924321475,0.0426413317328381,-0.0458633177642152,0.12129070262851,0.376466584676828
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51270,0.0224045890336488,0.087992876245648,-0.150061448407821,0.194870626475119,0.799019899786608
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51270,0.186633201176818,0.0761906175514534,0.0372995907759689,0.335966811577666,0.0143094502243966
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51270,0.0322487182888887,0.0276908842551296,-0.0220254148511653,0.0865228514289426,0.244192330213876
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51270,0.0236040511393769,0.0350285365491107,-0.0450518804968801,0.0922599827756339,0.500411062151443
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51270,0.0109505709408803,0.0143809030994627,-0.0172359991340665,0.0391371410158272,0.446385239904982
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33323,0.0104687013783414,0.0269671580954912,-0.0423869284888214,0.0633243312455042,0.697875377098431
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33323,0.109336241134337,0.0303245233303721,0.0499001754068076,0.168772306861866,0.000313108551663005
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33323,0.0487750109851391,0.0394824572825458,-0.0286106052886507,0.126160627258929,0.21672757400602
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33323,-0.00640173957008793,0.0115603733664148,-0.029060071368261,0.0162565922280852,0.579752211036778
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35441,-0.0125155979450625,0.0134463505709462,-0.038870445064117,0.013839249173992,0.351986634324513
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35441,-0.00872237291085411,0.0108863080042827,-0.0300595365992482,0.0126147907775399,0.423018328682955
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35441,0.00419040232777582,0.0107762823743469,-0.0169311111259441,0.0253119157814958,0.697391175785074
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35442,0.0200799502029996,0.0262183870732549,-0.0313080884605801,0.0714679888665793,0.443767583669889
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35442,0.0537481694870163,0.0171129942481175,0.020206700760706,0.0872896382133267,0.00168921936899188
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35442,0.00851658178528312,0.0214356075522384,-0.0334972090171041,0.0505303725876704,0.691146176637665
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51316,-0.00773503911155485,0.0249180277410615,-0.0565743734840353,0.0411042952609256,0.756244402791373
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51316,-0.00727855654862063,0.0162378743331823,-0.0391047902416579,0.0245476771444166,0.653979456791036
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51316,-0.0691384031570179,0.0486350560990727,-0.1644631131112,0.0261863067971647,0.155160885861959
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51316,-0.0258132725483186,0.0184262308806282,-0.0619286850743499,0.0103021399777128,0.161255837285573
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51316,-0.0397562601287428,0.0203213101835284,-0.0795860280884585,7.35078309728396e-05,0.050430208832538
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51316,0.0509362017112287,0.0223076104367737,0.00721328525515234,0.0946591181673051,0.0224170489680051
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51316,0.0146786969711324,0.00719820224396344,0.000570220572964037,0.0287871733693007,0.0414379221630149
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27969,0.0987253130170683,0.0235618568050309,0.0525440736792077,0.144906552354929,2.84754425853468e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27969,0.0793217586934213,0.0300035338400294,0.0205148323669637,0.138128685019879,0.0082305401234964
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27969,-0.0431126257281868,0.0219401857961137,-0.0861153898885696,-0.000109861567804015,0.0494806626188625
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27969,-0.00843171701706035,0.0181587358607472,-0.0440228393041248,0.0271594052700041,0.642433124786821
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51451,0.0160479693999327,0.00769970089849781,0.00095655563887698,0.0311393831609884,0.0371481695957727
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51451,0.0014625983092151,0.02261717869108,-0.0428670719253016,0.0457922685437318,0.948439141266044
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51451,0.022246609808934,0.00778036567652237,0.00699709308295015,0.0374961265349178,0.00424859124773468
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51451,0.00868186832876709,0.0075592766777804,-0.00613431395968249,0.0234980506172167,0.250770037774693
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51451,0.0118834928216377,0.0109294313588049,-0.00953819264161982,0.0333051782848952,0.276916895474529
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51451,0.0253633211955243,0.0112491914797263,0.00331490589526079,0.0474117364957878,0.0241612617048899
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51451,0.00683525634888091,0.0083264499409624,-0.00948458553540539,0.0231550982331672,0.411705288761808
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51451,0.0783551511007412,0.0239552629742443,0.0314028356712225,0.12530746653026,0.00107339171806734
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42515,-0.0163797968098328,0.00807226538685347,-0.0322014369680656,-0.000558156651599959,0.042457695496734
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42515,0.0031164693814882,0.00847566093007787,-0.0134958260414644,0.0197287648044408,0.71310385204989
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42515,-0.00375869706734692,0.0101367649205327,-0.023626756311591,0.0161093621768972,0.710791840724251
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42516,-0.00435785079744272,0.0139644612627137,-0.0317281948723616,0.0230124932774762,0.754992915090877
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42516,-0.00611748323435244,0.00894212691743708,-0.0236440519925291,0.0114090855238242,0.49390821821479
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51212,-0.00961087754203087,0.00854444844724405,-0.0263579964986292,0.00713624141456747,0.260679600876923
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51212,-0.0098245444270119,0.00669794149186995,-0.022952509751077,0.0033034208970532,0.142441810404586
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51212,-0.0106185396039557,0.00799350194887185,-0.0262858034237446,0.0050487242158331,0.184058255180954
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51212,-0.0204079546061317,0.0124327432944662,-0.0447761314632854,0.00396022225102196,0.100711729016536
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51228,-0.0229832226721231,0.0073563913762421,-0.0374017497695576,-0.00856469557468854,0.00178443658826847
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51228,-0.0159242713849059,0.010092624685116,-0.0357058157677333,0.00385727299792153,0.114620203331911
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51316,-0.0177231723926291,0.00775759295514669,-0.0329280545847167,-0.00251829020054163,0.0223425584013801
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51316,-0.00943127972351933,0.009553946203268,-0.0281570142819246,0.00929445483488594,0.323572589162846
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51316,-0.00537662885601258,0.0143243607286265,-0.0334523758841205,0.0226991181720953,0.707404120001215
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51316,-0.0480410377395182,0.0166941558058697,-0.0807615831190228,-0.0153204923600137,0.00400874531281895
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51316,0.00397055417473742,0.0164834355778774,-0.0283369795579023,0.0362780879073772,0.809648783598214
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51316,-0.033221271671001,0.0234947633437806,-0.0792710078248109,0.0128284644828089,0.157377286314166
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39505,-0.0110894585339561,0.00474418612281788,-0.0203880633346791,-0.00179085373323305,0.0194265797249475
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X864.Number of days or week walked 10+ minutes,50941,-0.00826867646450372,0.0203723590746448,-0.0481985002508076,0.0316611473218002,0.68483602417965
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X874.Duration of walks,47392,0.00370200522376447,0.00347937768467043,-0.00311757503818958,0.0105215854857185,0.287346469925788
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50230,0.00530521284493739,0.0198255212125551,-0.0335528087316706,0.0441632344215453,0.789013076449226
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X894.Duration of moderate activity,44247,0.0264792493576192,0.0237562483022191,-0.0200829973147302,0.0730414960299686,0.265025355737345
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30138,0.00856187866769172,0.00696472974677116,-0.00508899163597976,0.0222127489713632,0.218998079305643
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50237,-0.0335842021974629,0.0204913913465936,-0.0737473292367864,0.00657892484186052,0.101237265581612
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X914.Duration of vigorous activity,39432,0.0049408708023589,0.00433613903107175,-0.00355796169854173,0.0134397033032595,0.254527541087374
